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In the heterogeneous hub represented by the lateral hypothalamus, neurons containing
the orexin/hypocretin peptides play a key role in vigilance state transitions and
wakefulness stability, energy homeostasis, and other functions relevant for motivated
behaviors. Orexin neurons, which project widely to the neuraxis, are innervated by
multiple extra- and intra-hypothalamic sources. A key property of the adaptive capacity
of orexin neurons is represented by daily variations of activity, which is highest in the
period of the animal’s activity and wakefulness. These sets of data are here reviewed.
They concern the discharge profile during the sleep/wake cycle, spontaneous Fos
induction, peptide synthesis and release reflected by immunostaining intensity and
peptide levels in the cerebrospinal fluid as well as postsynaptic effects. At the synaptic
level, adaptive capacity of orexin neurons subserved by remodeling of excitatory and
inhibitory inputs has been shown in response to changes in the nutritional status and
prolonged wakefulness. The present review wishes to highlight that synaptic plasticity in
the wiring of orexin neurons also occurs in unperturbed conditions and could account
for diurnal variations of orexin neuron activity. Data in zebrafish larvae have shown
rhythmic changes in the density of inhibitory innervation of orexin dendrites in relation
to vigilance states. Recent findings in mice have indicated a diurnal reorganization of
the excitatory/inhibitory balance in the perisomatic innervation of orexin neurons. Taken
together these sets of data point to “chronoconnectivity,” i.e., a synaptic rearrangement
of inputs to orexin neurons over the course of the day in relation to sleep and wake
states. This opens questions on the underlying circadian and homeostatic regulation
and on the involved players at synaptic level, which could implicate dual transmitters,
cytoskeletal rearrangements, hormonal regulation, as well as surrounding glial cells and
extracellular matrix. Furthermore, the question arises of a “chronoconnectivity” in the
wiring of other neuronal cell groups of the sleep-wake-regulatory network, many of
which are characterized by variations of their firing rate during vigilance states.
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INTRODUCTION
A wealth of studies has been stimulated by the discovery, two
decades ago, of neurons of the lateral hypothalamus (LH) which
synthesize the orexin/hypocretin peptides (de Lecea et al., 1998;
Sakurai et al., 1998). Interest in these neurons has been boosted
by findings that rapidly accumulated on their role in food intake,
in the promotion and consolidation of wakefulness, as well as
in a wide range of other physiological functions relevant for
motivated behaviors.
These functions require capacity of adaptation to the internal
milieu of the organism and to the external environment. Daily
variations of activity, demonstrated for orexin neurons, are
essential for such adaptation. At the synaptic level, adaptation
should be subserved by plasticity. Seminal investigations have
shown plastic synaptic changes in the excitatory wiring of orexin
neurons after changes in food intake or prolonged wakefulness
(Horvath and Gao, 2005; Rao et al., 2007). Such findings
have focused attention on the response of these neurons to
perturbations of physiological functions. The present review
wishes to highlight that plastic changes of the wiring of orexin
neurons occur also in unperturbed animals over the course of the
day and in relation with sleep or wakefulness.
The orexin system and sources of inputs to orexin neurons
are here first summarized. This is followed by a review of
different lines of evidence pointing to daily variation of the
activity of orexin neurons and to remodeling of their synaptic
wiring in response to challenges. Dynamic changes in the
synaptology of orexin neurons in basal conditions are then
discussed. Altogether the findings point to daily variations in
the excitatory/inhibitory wiring of orexin neurons as operational
mode of these neurons inserted in a network that should meet
daily demands.
OVERVIEW OF THE OREXIN SYSTEM
The orexin system has been the subject of authoritative reviews
(e.g., Yamanaka et al., 2003a; Sakurai, 2007, 2014; Sakurai and
Mieda, 2011; Kukkonen, 2013; Bonnavion et al., 2016; Peyron and
Kilduff, 2017; Tyree et al., 2018) and only a brief synopsis is here
presented.
Orexin-A and orexin-B are also named hypocretin-1 and -2,
and the double nomenclature is due to the designation of the
molecules at the time of their discovery. These paired peptides
are synthesized by neurons located in the perifornical area and
LH (Peyron et al., 1998). The orexins are cleaved by a proteolytic
process from the common precursor prepro-orexin, a 130 amino
acid molecule encoded by a single gene (located in humans
in chromosome 17), into two smaller peptides, which share 13
amino acid identities and are highly conserved across species in
mammals and non-mammalian vertebrates (Kukkonen, 2013).
Orexin-A and B are largely colocalized in the same neurons,
as shown in the human (Thannickal et al., 2000) and rodent
(Nixon and Smale, 2007) brain. Orexin-A is more stable and
lipophilic than orexin-B (Kastin and Akerstrom, 1999), and can
be measured in the cerebrospinal fluid (CSF). We will here refer
to orexin-A or both orexin-A and -B as orexin, unless explicitly
specified.
Orexin neurons represent a relatively small population: about
7,000 neurons in the rat brain (Modirrousta et al., 2005) and
50,000–80,000 neurons in the human brain (Thannickal et al.,
2000; Steininger and Kilduff, 2005).
Orexin actions are mediated by two membrane-bound G
protein-coupled receptors: orexin-1 receptor (OX1R) and orexin-
2 receptor (OX2R) (Sakurai et al., 1998; Inutsuka and Yamanaka,
2013). OX1R is linked to excitatory G proteins of the Gq
subclass, and OX2R can signal through Gq or inhibitory
Gi/Go proteins. OX1R has greater affinity for orexin-A over
orexin-B, whereas OX2R accepts both ligands with similar
affinities. The different complementary distribution of OX1R and
OX2R mRNAs suggests that these receptors enhance distinct
physiological roles in diverse brain regions (Marcus et al., 2001).
The study of the distribution of orexin fibers rapidly
revealed that they establish a rich network within the LH and
other hypothalamic regions, including the dorsomedial and
ventromedial hypothalamic nuclei, arcuate nucleus, as well as
the wake-promoting histaminergic tuberomammillary nucleus
(TMN) (Peyron et al., 1998; Eriksson et al., 2001; Peyron and
Kilduff, 2017). Orexin projections extend widely beyond the
hypothalamus, innervating the neocortex and hippocampus,
forebrain structures implicated in the processing of emotion
and motivation, such as the amygdala, nucleus accumbens, bed
nucleus of the stria terminalis (BNST), and ventral tegmental
area (Peyron et al., 1998). In the thalamus, orexin axons
course along the midline and are densely distributed in the
thalamic paraventricular nucleus (review in Colavito et al., 2015).
Targets of orexin fibers in the brain stem include key nodes
in sleep-wake regulation: noradrenergic neurons of the locus
coeruleus and serotonergic neurons of the dorsal raphe (Peyron
et al., 1998; Horvath et al., 1999). Descending orexin fibers are
distributed to all segments of the spinal cord, densely innervating
the intermediolateral cell column, with a moderately dense
distribution to the ventral horn (van den Pol, 1999). Orexin fibers
have been found to be apposed to motoneuron cell bodies, as
described at lumbar spinal levels (Yamuy et al., 2004).
The orexin peptides were first recognized as regulators of
feeding behavior (Sakurai et al., 1998) and orexin neurons
are connected to hypothalamic regions that regulate energy
balance. The targets mentioned above indicated that these
neurons are also inserted in the network of sleep-wake regulation.
Demonstrating a role of orexin in this function, features of
the sleep disorder narcolepsy were found in murine models of
deficient orexin signaling (Chemelli et al., 1999; Lin et al., 1999).
Interest in the involvement of orexin neurons in sleep-wake
regulation was also stimulated by the finding that they degenerate
in the brain of subjects affected by narcolepsy (Thannickal
et al., 2000) and in particular the form of narcolepsy with
cataplexy currently classified as narcolepsy type I (Scammell,
2015). Optogenetic investigation has demonstrated a role of
orexin in the regulation of sleep-wake transitions (Adamantidis
et al., 2007).
Of note, orexin neurons link limbic regions and arousal-
regulating regions, and the activation of orexin neurons by the
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limbic system could be instrumental in maintaining wakefulness
during emotional arousal (Sakurai, 2014). In humans, increased
levels of orexin, measured in the amygdala, have been found
during social interactions and in connection with social-induced
positive emotions (Blouin et al., 2013).
The orexin system also regulates autonomic functions and the
neuroendocrine axes, as well as plasticity mechanisms related
to reward (López et al., 2010; Giardino and de Lecea, 2014;
Baimel et al., 2015). Furthermore, the orexin system has been
implicated in cognitive processes, e.g., in the facilitation of
hippocampal-dependent learning and memory functions (Aitta-
Aho et al., 2016; Mavanji et al., 2017), and in the modulation
of γ-aminobutyric acid (GABA) and glutamate release in the
hippocampus (Stanley and Fadel, 2012), in fear memories (Flores
et al., 2014) and in the modulation of amygdala-dependent
aversive memory formation (Sears et al., 2013).
Furthermore, orexin neurons innervate brain regions related
to nociception, especially the periaqueductal gray (Hagan et al.,
1999; Ho et al., 2011), and play a role in the link between
nociception and analgesia (Cristino et al., 2016; Inutsuka et al.,
2016; Razavi and Hosseinzadeh, 2017).
These broad range of functions has led to the definition
of orexin neurons as “physiological integrators” (de Lecea
et al., 1998; Inutsuka and Yamanaka, 2013) and “multitasking”
(Sakurai, 2014).
Multitasking Neurotransmission
Orexin neurons are multitasking also concerning
neurotransmitters. Orexin is excitatory (de Lecea et al., 1998) and
a wealth of evidence indicates that orexin neurons co-release the
excitatory neurotransmitter glutamate. It was initially reported
that orexin cell bodies show glutamate immunoreactivity
(Abrahamson et al., 2001), and optogenetic activation has
more recently shown glutamate release (Schöne et al., 2014).
A recent study in genetically engineered mice has reported that
about 86% of orexin neurons express the vesicular glutamate
transporter-2 (VGluT2), a marker for glutamate-releasing
neurons (Blanco-Centurion et al., 2018).
In early ultrastructural studies, orexin axon terminals in the
TMN were found to establish asymmetric synapses (Torrealba
et al., 2003), though both symmetric and asymmetric contacts
of orexin boutons were also reported (Yamanaka et al., 2002).
Asymmetric synapses and some symmetric synapses established
by orexin fibers have been observed in other targets (review in Ma
et al., 2018). It was also shown that at the presynaptic terminal
glutamate is stored in small, clear, synaptic vesicles, whereas
orexin is contained in large, dense core vesicles, which suggested
a different regulation of the release of the fast neurotransmitter
and the peptide (Torrealba et al., 2003). Fast glutamatergic
control of orexin axons in the TMN (Schöne et al., 2012), with a
differential regulation of glutamate and orexin spike outputs was
then actually shown by optogenetic stimulation (Schöne et al.,
2014), and this confirmed glutamate and orexin co-transmission
in targets of orexin efferents.
There are also findings indicating that a subset of orexin
neurons (about 10–20%) may release GABA, and that
they exert a direct local inhibitory effect on neurons which
contain melanin-concentrating hormone (MCH; see further)
(Apergis-Schoute et al., 2015). By single-cell gene profiling
expression of the gene encoding glutamate decarboxylase (GAD,
the GABA synthetic enzyme) 65 was found in about 50% of
orexin neurons, which would therefore be potentially capable of
GABA synthesis (Mickelsen et al., 2017). This adds complexity to
potential inhibitory effects of orexin neurons, which could also
be mediated by disinhibition of local GABAergic neurons in the
LH (e.g., Belle et al., 2014; Apergis-Schoute et al., 2015).
Orexin neurons also co-express other peptides (review in Ma
et al., 2018). Among these, the colocalization with the inhibitory
peptide dynorphin (Chou et al., 2001) seems to be of particular
interest for synergistic functional effects of local release (Ferrari
et al., 2018), as outlined below.
Wiring of Orexin Neurons: Extra- and
Intra-hypothalamic Inputs
The normal synaptic organization of orexin neurons has
been initially examined in intact mice used as controls of
manipulations of food intake (Horvath and Gao, 2005). This
study was based on electrophysiological approaches (whole-
cell recording in lateral hypothalamic slices from mice in
which orexin neurons are tagged by green fluorescent protein,
GFP), ultrastructure (identification of asymmetric, i.e., putative
excitatory, and symmetric, i.e., putative inhibitory, synapses),
fluorescence immunostaining of presynaptic components using
VGluT2 to label excitatory axon terminals and GAD to label
GABAergic ones. Altogether these approaches provided evidence
in control animals (fed ad libitum) of a dense excitatory
innervation of orexin cell bodies: immunofluorescence showed a
5:1 ratio of excitatory/inhibitory perisomatic input, and electron
microscopy showed a ratio of about 2:1 of asymmetric versus
symmetric contacts on dendrites. Excitatory synaptic currents
were consistent with the prevalence of excitatory innervation
of orexin neurons. Furthermore, dendro-dendritic interactions
were prominent among orexin-immunopositive shafts and
unidentified dendritic shafts of LH neurons. Since the receptor
for the adipose hormone leptin is expressed at orexin neurons,
a relationship between the levels of circulating leptin and
the synaptic arrangement was hypothesized and verified with
paradigms of fasting and re-feeding and leptin administration.
The animals were maintained under a 12 h/12 h light/dark
(LD) cycle. Although the time of sacrifice was not explicitly
mentioned, on the basis of the experimental protocol (overnight
food deprivation) the animals were presumably sacrificed at the
end of the period of darkness.
The predominantly excitatory synaptic organization of orexin
neurons described in this study was defined as “unorthodox”
compared to other neuronal cell types in the central nervous
system (Horvath and Gao, 2005), especially concerning
perisomatic innervation. For example, in pyramidal cells of the
CA1 hippocampal field and neocortex, the cell body receives
GABAergic inhibitory terminals, whereas most of the excitatory
inputs target dendrites (Megías et al., 2001; Spruston, 2008).
The sources of excitatory and inhibitory afferents to
orexin neurons are diverse and represent a complex chapter
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of their connectivity and functional effects. Afferents have
been investigated by methods with increasing selectivity and
sensitivity: conventional tract tracing techniques, genetic
tracing, neurochemical identification of boutons with multiple
immunofluorescence, optogenetics. Altogether this wealth of
data has shown that neural inputs originate from a variety of
extra-hypothalamic sources, which do not always reciprocate
orexin projections, and from intra-hypothalamic sources,
including a dense network within the LH.
In particular, overall mapping of afferents to orexin neurons
has been performed with anterograde tract tracing based on
injections of biotinylated dextran, combined with retrograde
tracing with cholera toxin B subunit in rats (Yoshida et al.,
2006), and retrograde tracing using transgenic mouse lines which
express tetanus toxin C fragment fused to GFP (TTC::GFP
transgene) in orexin neurons (Sakurai et al., 2005). These
studies have shown that cortical input derives from the limbic
(infralimbic and prelimbic) cortex, and dense afferents originate
from the basal forebrain, amygdala, septum, nucleus accumbens
and BNST. Many hypothalamic sources have been identified:
preoptic area, GABAergic neurons of the sleep-promoting
ventrolateral preoptic nucleus (VPLO), posterior hypothalamus,
arcuate nucleus and LH. Afferents from the brain stem derive
mainly from cholinergic neurons of the mesopontine nuclei and
serotonergic neurons of the raphe nuclei.
Concerning the abundant input from the basal forebrain
(Henny and Jones, 2006), conditional anterograde tracing of
neurotransmitter-identified circuits has shown that the substantia
innominata sends glutamatergic and GABAergic fibers to orexin
neurons (Agostinelli et al., 2017). Optogenetic stimulation has
shown that this glutamatergic input excites orexin neurons,
whereas, surprisingly, the GABAergic input, though equally
dense, rarely forms functional synapses (Agostinelli et al., 2017).
Glutamatergic axons derived from local neurons and/or
other hypothalamic and extra-hypothalamic sources have been
reported to account for excitatory inputs to orexin neurons
(Li et al., 2002). Electrophysiological recordings from slice
preparations showed that orexin neurons are activated by
agonists of ionotropic glutamate receptors and inhibited by
glutamate antagonists (Li et al., 2002; Yamanaka et al., 2003b),
indicating that orexin neurons are tonically activated by
glutamate (review in Inutsuka and Yamanaka, 2013).
The local network in the LH, which is formed by
heterogeneous neuronal subsets (Gerashchenko and Shiromani,
2004; Burt et al., 2011) plays an important role in orexin neuron
activity regulation. Results from immuno-electron microscopy
analyses and patch-clamp recordings in slices have shown that
orexin neurons directly innervate each other, and are indirectly
activated via OX2R (Yamanaka et al., 2010). Furthermore,
excitatory inputs to orexin somata originate from hypothalamic
neurons which produce corticotropin releasing hormone, and
this could represent a pathway for stress-induced activation of
the orexin system, given the role of these neurons in the response
to stress (Winsky-Sommerer, 2004). In addition, neurotensin-
immunoreactive fibers contact orexin neurons and could be
implicated in maintaining their activity (Leinninger et al., 2011;
Furutani et al., 2013).
Inhibitory inputs to orexin neurons also derive from
multiple sources, including, within the LH, MCH neurons, as
dealt with below. GABAergic afferents include somatostatin-
containing varicosities, and these express the vesicular GABA
transporter (VGAT) (Toossi et al., 2012). GABAergic neurons
with electrophysiological properties distinct from those of orexin
and MCH neurons have been reported in the LH (Karnani
et al., 2013). These include neurons which express the leptin
receptor (Leinninger et al., 2009) and directly innervate orexin
neurons (Louis et al., 2010). Neurons which express the gut
hormone ghrelin also suppress orexin neuron activity (Horvath
et al., 2012). A recent report has confirmed that input to orexin
neurons derives from a variety of GABAergic neurons within
the LH (Ferrari et al., 2018). This local inhibitory input is
depressed by acetylcholine; furthermore dynorphin, likely to be
released locally from orexin neurons, inhibits orexin neurons
directly but also disinhibits them indirectly by depressing the
input derived from local GABAergic neurons (Ferrari et al.,
2018).
In addition, inhibitory functional glycine receptors and
glycinergic synapses onto orexin neurons have been identified
by electrophysiology and immuno-electron microscopy (Hondo
et al., 2011).
Monoamine neurotransmitters such as dopamine,
noradrenaline, and serotonin also regulate the state-dependent
activities of orexin neurons through inhibition via their receptors,
such as D1/D2- (Bubser et al., 2005), alpha 2-adrenergic- (Li
and van den Pol, 2005) and 5-HT1A- receptors (Muraki, 2004),
respectively.
The Interplay With MCH Neurons
These cells are of special interest because they have been
implicated in functions regulated also by orexin neurons, such
as energy balance and sleep (Guyon et al., 2009; Bittencourt,
2011; Konadhode et al., 2013; Ferreira et al., 2017), autonomic
functions (Adamantidis and de Lecea, 2009) and emotional
behavior (Blouin et al., 2013).
Melanin-concentrating hormone neurons are distributed over
other areas besides the LH (Bittencourt, 2011) but are largely
intermingled with orexin neurons in the LH. These two cell
groups play opposite roles in energy balance and especially in
the regulation of sleep-wake states. MCH neurons promote sleep:
they are active during rapid eye movement (REM) sleep, inactive
during wakefulness (Hassani et al., 2009), and their optogenetic
activation leads to REM and non-REM sleep in rats (Blanco-
Centurion et al., 2016). Of note, at variance with orexin neurons
MCH neurons are spared in the brain of narcoleptics (Thannickal
et al., 2000, 2009).
Whole brain-mapping in mice has shown that afferents to
MCH and orexin neuronal populations share many common
sources, though it is not known whether the same cells innervate
both peptidergic populations (González et al., 2016). MCH
efferents are widely distributed and their axon terminals establish
symmetric contacts (Bittencourt, 2011). In the local LH network
they contribute to the synaptic inputs to orexin neurons (Bayer
et al., 2002; Guan et al., 2002; Burt et al., 2011) exerting on them
an inhibitory effect (Konadhode et al., 2015). Most MCH cells
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express GAD and are therefore GABAergic, but with the puzzling
feature that they do not express VGAT (review in Herrera
et al., 2017), as also confirmed by recent findings in transgenic
mice (Blanco-Centurion et al., 2018) and by single-cell profiling
indicating that GABA release from MCH neurons could either
be non-synaptic or occur via non-canonical pathways (Mickelsen
et al., 2017).
DIURNAL CHANGES OF OREXIN
NEURON ACTIVITY
Given the role of the LH in physiological functions critical
for survival which undergo substantial changes during 24 h
(e.g., food intake and metabolism, vigilance states), it may not
be surprising that diurnal (i.e., happening over a period of a
day: day versus night), daily (i.e., happening every day) and
circadian (circa diem: recurring over a 24 h cycle) changes
have been reported in the LH. For example, gene profiling in
mice from tissue punches collected from VPLO, suprachiasmatic
nucleus (SCN) and LH has shown a diurnal fluctuation in gene
expression, with difference and overlap in these regions between
day and night (Gerstner et al., 2006).
It is worth recalling, in this respect, that functional,
cellular, molecular fluctuations in the hypothalamus during
24 h have been related in different studies to day and
night, to the animal’s rest and locomotor activity, and/or to
vigilance states. In laboratory rodents, which are nocturnal,
the light period corresponds to that of rest and predominant
sleep, and the period of darkness to activity and wake
predominance. The definition of vigilance states requires,
however, electrophysiological characterization.
State-dependent behavior, in which all behavioral
performances are inscribed, consists of three vigilance states:
wake, REM sleep (also called paradoxical sleep, PS), non-REM
sleep (also referred to in rodents as slow wave sleep, SWS),
defined by neurophysiological parameters and, in particular
electroencephalogram (EEG) recording. In model organisms
such as the zebrafish, in which EEG cannot be recorded, sleep-like
state is defined by behavioral criteria, based on the spontaneous
occurrence of immobility with a circadian rhythm and under
homeostatic control (Elbaz et al., 2013).
It should be noted, however, that in many studies of molecular,
cellular or electrophysiological features of orexin neurons the
time of the day of the study (including the time of the
animals’ sacrifice, the time of preparation of brain slices, etc.)
is not specified in the methodology, which therefore hampers a
correlation with time of the day-dependent parameters.
Neuronal Firing Profile
Most neuronal populations (such as dopaminergic, GABAergic,
cholinergic, serotonergic neurons) in the sleep-wake network
show diurnal variations in the profile of discharge that vary
in strict dependency on the release of their neurotransmitter
(Tyree and de Lecea, 2017). The interactions between different
neuronal populations and their specific daily fluctuations result in
variations of EEG pattern which characterize different behavioral
stages (SWS, REM sleep, or wakefulness).
Consistently with a pivotal role of orexin neurons for arousal
promotion and maintenance, in rats entrained under the LD
cycle, single unit recordings across the sleep-wake cycle have
revealed a precise profile of discharge (Lee et al., 2005). Thus,
orexin neurons show a relatively high discharge rate during
active waking, the firing rate decreases ∼6 times during quiet
wakefulness, and they become virtually silent during SWS and
the transitions between quiet wake and SWS, as well as between
SWS and REM sleep. During REM sleep, orexin neurons remain
relatively silent, with an increase of firing rate only at the end of
REM sleep episodes (Lee et al., 2005) (Figures 1A,B).
The same pattern of spiking was reported in rats
(Mileykovskiy et al., 2005) and in mice (Takahashi et al.,
2008) by means of extracellular unit recordings. In these
studies, orexin neurons were found to be highly active during
active wakefulness, decrease their firing activity during quiet
wakefulness and become relatively silent during quiet SWS and
tonic periods of REM sleep, with occasional discharges during
phasic periods of REM sleep. Moreover, a correlation with
electromyogram (EMG) activity, and therefore with muscle tone,
was shown (Mileykovskiy et al., 2005).
Spontaneous Fos Induction
Other sets of data derive from the investigation of Fos expression.
This nuclear protein, encoded by the immediate early gene c-
fos, is a widely used marker of neuronal activity, induced by
different stimuli (Herdegen and Leah, 1998). However, Fos is also
expressed in basal conditions in different cell groups of the brain,
with a spontaneous oscillation during 24 h (Grassi-Zucconi et al.,
1993, 1994; Cirelli et al., 1995).
In the LH, Fos is expressed in basal conditions in orexin,
MCH, non-orexin and non-MCH neurons, as shown in rats
(Verret et al., 2003; Modirrousta et al., 2005). In undisturbed
rats maintained under the LD cycle, the number of orexin
neurons showing Fos-immunoreactive nuclei is higher during
night than day (Estabrooke et al., 2001) (Figure 1C). This was
also documented when rats were maintained under constant
darkness, indicating an endogenous oscillation (Estabrooke et al.,
2001) (Figure 1C). In addition, EEG recording showed a positive
correlation between Fos expression in orexin neurons and the
amount of wakefulness and a negative correlation with the
amount of sleep (non-REM and REM sleep) in the 2 h preceding
the animal’s sacrifice (Estabrooke et al., 2001). During the light
period, however, orexin neurons can be activated, as shown by
Fos induction, when mice are working for reward (McGregor
et al., 2011), and are activated during positively reinforced
tasks in mice exposed to constant light (Marston et al., 2008),
further supporting a motivational specificity of the orexin arousal
function.
Fos expression in a higher number of orexin neurons during
the period of activity than rest was also seen in diurnal rodents
(Martínez et al., 2002; Kodama et al., 2005).
The use of Fos as a tool to disentangle the effects of wake
and locomotor activity in rats suggested an association of
locomotor activity, rather that waking per se, with increased
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FIGURE 1 | The activity of orexin neurons shows a diurnal fluctuation. (A,B) Neuronal firing rate. (A) Schematic representation of methodology used by Lee et al.
(2005). Rats were implanted with epidural electroencephalographic electrodes (gray screws on skull) and with a metal bar for holding the head fixed while recording.
A hole was drilled in skull to insert a glass micropipette for recording single unit from orexin neurons in the lateral hypothalamus. (B) Representative results found by
Lee et al. (2005): the firing rate in arbitrary units (a.u.) of orexin-positive neurons varied significantly as a function of vigilance states. During active wakefulness (aW, in
yellow) firing rate was highest and decreased during quiet wakefulness (qW, in green). The discharge was virtually absent during transitions between wakefulness
and slow wave sleep (tSWS), during slow wave sleep (SWS, in blue) as well as during transitions between SWS and paradoxical sleep (tPS). During paradoxical
sleep (PS, in orange) spike rate showed a little increase. Similar results was reported in rats by Mileykovskiy et al. (2005). (C,D) The figurines indicate laboratory
rodents (findings depicted in C were obtained in rats, and those depicted in D in mice). LD indicates 12 h light/dark cycle entrainment, under which hours are
referred to as Zeitgeber time (ZT; ZT0 corresponds to the lights-on time). DD indicates constant darkness, under which hours are referred to as circadian time (CT),
corresponding to subjective light time (indicated by the sun in DD) and subjective dark time. (C) Spontaneous Fos induction. Schematic illustration of results found
by Estabrooke et al. (2001). Double-label immunohistochemistry was performed to measure Fos expression in orexin neurons of the perifornical area. Under the LD
cycle orexin-positive neurons showed higher (about two times) Fos immunoreactivity during the night (ZT15-ZT21; on the right) than during the day (ZT3-ZT9; on the
left). The same pattern of activation still occurred in DD, indicating an endogenous rhythm. (D) Orexin synthesis: Schematic illustration of results found by McGregor
et al. (2017). Immunohistochemistry was performed to count orexin neurons, and the number by orexin-positive neurons was found to be higher (about 24%
increase) during the night (LD, ZT17, on the right) than the day (LD, ZT5, on the left).
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orexin neurotransmission (España et al., 2003). This issue has
been examined also with other approaches, as it will be discussed
further.
Orexin Synthesis and Release
It has been generally assumed that the number of orexin neurons
detectable by immunocytochemistry does not vary across
different behavioral states. A recent study has instead reported
a diurnal variation in the number of immunolabeled orexin
neurons (McGregor et al., 2017) (Figure 1D). A significantly
greater number (24% increase) of orexin-immunopositive
neurons, without significant changes in soma size, was
found in undisturbed mice sacrificed during the dark
phase compared to the light phase. The finding indicates
that orexin expression does not reach the threshold for
immunocytochemical detection in all orexin neurons during
the phase of the animal’s rest. In contrast, there was no
significant difference in the number of MCH-immunoreactive
neurons between the animals in either phase, but a 15%
increase in the soma size of MCH cells was found during
the light phase compared to the dark phase (McGregor et al.,
2017).
Other lines of evidence of diurnal fluctuation concern orexin
synthesis. An initial study (Taheri et al., 2000) has reported in rats
a diurnal variation in prepro-orexin mRNA in the hypothalamus
and orexin immunoreactivity (measured by radioimmunoassay
in brain homogenates) with a decrease during the day and an
increase at night, in the preoptic/anterior hypothalamus and
the pons, but not in other brain areas. Microdialysis and EEG
(polysomnography) recordings showed a diurnal fluctuation of
extracellular levels of orexin in the LH and medial thalamus of
rats, with increase during the period of darkness and a decrease
during the light period (Yoshida et al., 2001). In this study, in
which the animals were also sleep-deprived for 6 h, orexin level
was found to be dissociated from the amount of sleep and wake,
favoring a role of orexin release in homeostatic processes. In cats
in which vigilance states were characterized by EEG, local release
of orexin measured with microdialysis was found to peak during
active waking (Kiyashchenko et al., 2002).
Consistent with the role of orexin neurons in wakefulness and
energy homeostasis, orexin level in the CSF of rats was found to
be high during the period of darkness with a decrease in the light
period (Fujiki et al., 2001; Desarnaud et al., 2004), and an increase
after sleep deprivation (Desarnaud et al., 2004), as well as after
food deprivation (Fujiki et al., 2001). In the cat, orexin level in
the CSF was markedly higher during active waking than quiet
waking, favoring a correlation with motor activity (Kiyashchenko
et al., 2002).
In squirrel monkey, a diurnal non-human primate, the orexin
level of cisternal CSF was found to exhibit a strong diurnal
pattern with increasing concentration during the wake period
and maximum levels in the early evening (the latter third of the
wake period), falling then throughout the night (Zeitzer et al.,
2003). Prolongation of daytime wakefulness for about 4 h did
not result in significant change in CSF orexin levels, whereas
sleep deprivation during the night resulted in significant increase
in CSF orexin levels. Orexin thus appeared to act as a reactive
homeostatic signal, with a circadian contribution opposite to
sleep drive (Zeitzer et al., 2003).
In humans, the interpretation of findings on orexin levels in
the CSF, which seem to increase during sleep, is complicated
by the sampling times and by the methodology, represented by
the lumbar puncture (in contrast to sampling from the cisterna
magna in experimental animals), due to which the temporal
profile may differ, being delayed, from that of brain regions
(Salomon et al., 2003; Grady et al., 2006). It is interesting to
note, however, that seasonal changes in orexin level in the CSF
have been reported in humans, with 10–12% change from winter
to summer, correlating with day length period but not with
measures of sleep length (Boddum et al., 2016).
Diurnal variations of postsynaptic effects of orexin, especially
relevant in the present context, have been studied in hippocampal
subfields (Perin et al., 2014). In acute hippocampal slices prepared
from rats during daytime (the period of rest), exogenous
orexin was found to exert an inhibitory effect on mossy fibers
synapses. This inhibition, mediated by OX2R, was absent in
slices prepared at the end of the night (Perin et al., 2014).
The findings point to time-of-day-dependent postsynaptic effects
of orexin release, at least in some of its targets. In the SCN,
orexin release exerts an inhibitory effect during both day and
night, but with different postsynaptic mechanisms (Belle et al.,
2014).
Plasticity in the Wiring of Orexin Neurons
After Food Intake and Sleep/Wake
Manipulations
Experimental manipulations of the main functions in which
orexin is involved, namely food intake and wake regulation, have
pointed out a remarkable synaptic plasticity.
The first data indicating that changes in the nutritional status
are able to affect synaptic plasticity of orexin neurons and their
connectivity derived from synaptology and electrophysiological
studies during fasting and re-feeding in mice (Horvath and Gao,
2005). Fasting was found to increase the number of excitatory
inputs to orexin somata with recruitment of additional terminals,
reaching a 10:1 ratio of excitatory versus inhibitory terminals
on orexin cell bodies; re-feeding after fasting partially reversed
these fasting-induced changes. Since administration of leptin
prevented fasting-induced plasticity, it was proposed that the
rewiring of orexin neurons could result from multiple humoral
and neuronal signals, and that synaptic changes in the orexin
circuitry could underlie functional alterations such as insomnia,
and metabolic disturbances including obesity (Horvath and Gao,
2005).
Indeed, an excitatory-to-inhibitory switch of synapses on
orexin somata has been reported in obese mice, both in the
genetic model of obesity represented by leptin-deficient ob/ob
mice and in mice subjected to high-fat diet (HFD), a model of
diet-induced obesity (Cristino et al., 2013). In this study, in which
parameters related to retrograde endocannabinoid signaling
were examined, presynaptic inputs to orexin cell bodies were
characterized by double immunofluorescence of synaptophysin
combined with VGAT or VGluT2 and by the ultrastructural
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investigation of symmetric and asymmetric synaptic contacts. In
obese mice, the perisomatic innervation was found to change
from predominantly excitatory to predominantly inhibitory with
consequent endocannabinoid-mediated disinhibition of orexin
neurons and elevation of orexin trafficking and release to many
target areas.
The mechanism of such synaptic remodeling was also
investigated (Cristino et al., 2013), highlighting in obese mice a
role of lack of leptin in the arcuate nucleus, the source of most
of the fibers which express the (endo)cannabinoid receptor type
1 (CB1) and innervate orexin neurons. Treatment with leptin
reversed the synaptic remodeling but only in ob/ob mice and not
in HFD mice, indicating that this phenomenon is a consequence
of leptin deficiency or leptin resistance in the arcuate nucleus.
Interestingly, possibly because ob/ob mice lack endogenous leptin
when weaned but receive leptin from their heterozygous mothers
during lactation, synapse remodeling at orexin neurons only
occurred after weaning and was reversed by exogenous leptin
injection (Cristino et al., 2013; Becker et al., 2017).
Consistent with these findings and with data indicating
that experimental exposure to HFD induces various forms of
functional and structural plasticity within the reward circuitry
(Sharma et al., 2013), a recent report in rats has pointed out
plastic changes in orexin neurons following exposure to HFD
(a palatable high fat Western diet) (Linehan et al., 2018). Short-
term exposure to HFD increased the level of glutamate, thereby
priming excitatory synapses onto orexin neurons to undergo
activity-dependent long-term depression. However, this priming
was transient as it disappeared following prolonged exposure
to HFD. The observed changes may thus alter orexin network
properties and could also underlie their physiological role in
reward-based feeding (Linehan et al., 2018).
Dynamic remodeling of orexin neuron wiring has also
been described in response to changing physiological needs
such as sleep. Electrophysiological analysis in mice showed an
increased strength of glutamatergic synapses on orexin neurons
following prolonged wakefulness induced by modafinil treatment
or 4 h sleep deprivation, and ultrastructural analysis revealed
a significant increase in the number of asymmetric synapses
in modafinil-treated mice (Rao et al., 2007). Accordingly,
sleep-deprived or modafinil-treated mice showed increased
locomotor activity. The findings confirmed that physiological
or environmental cues lead to a reorganization of excitatory
synapses on orexin neurons and, in turn, experience-dependent
plasticity in orexin neurons may underlie prolonged wakefulness
(Rao et al., 2007, 2008).
Diurnal Changes in the Wiring of Orexin
Cell Bodies in Basal Conditions
The issue of the synaptology of orexin neurons in basal
conditions has been examined in the model organism zebrafish, a
diurnal vertebrate, and in mice.
About 16 orexin neurons are present in zebrafish larvae and
about 60 in the adult animals. The larvae are transparent, thus
allowing in situ live imaging studies. Orexin-A in zebrafish shares
32% amino acid sequence with that of the human peptide, and the
only identified OXR corresponds structurally to the mammalian
OX2R (Elbaz et al., 2013). Orexin neurons are glutamatergic also
in zebrafish (Appelbaum et al., 2009), and their expression during
arousal and their circuitry point to a role of orexin in vigilance
state transitions also in this species (Elbaz et al., 2013).
In vivo two-photon imaging revealed that the number of
presynaptic terminals of orexin neurons projecting to the pineal
gland show a circadian rhythmicity in both LD and constant
darkness conditions, excluding a light exposure effect. The
number of terminals was found to be highest over the subjective
light phase (activity period) and to decrease during the subjective
dark phase (rest period), highlighting a circadian control of the
orexin synapse arrangement (Appelbaum et al., 2010). Moreover,
6 h sleep deprivation in zebrafish resulted in an increase of∼17%
of orexin terminals, which returned to control levels in the sleep
recovery period (Appelbaum et al., 2010).
Concerning orexin neuron wiring, the number of inhibitory
synapses on orexin dendrites was found to peak in zebrafish
larvae during the night, i.e., during the period of rest of this
animal, and there were no changes under constant light or dark
conditions (Elbaz et al., 2017). During night, sleep deprivation
reduced the synapse number, which increased during the post-
deprivation daytime sleep (Elbaz et al., 2017). This rhythmic
plasticity of inhibitory synaptic contacts on orexin neuron
dendrites was found to be modulated by consolidated wake and
sleep, and therefore independent from the circadian clock (Elbaz
et al., 2017).
The issue of the diurnal balance between excitatory and
inhibitory inputs onto orexin somata in undisturbed mice
has been recently examined in our laboratories (Laperchia
et al., 2017). In this study, the animals were sampled at
two time points in antiphase during day and night. To
avoid any potential stressful condition, EEG was recorded
in matched mice showing, in the 2 h preceding sacrifice,
a predominance of sleep (about 70% of this time interval)
during day and a predominance of wake (about 71%) during
night (Figure 2). To characterize excitatory and inhibitory
terminals, the input to orexin cell bodies was visualized
using the presynaptic marker synaptophysin combined
with VGAT or VGluT2, as well as with each vesicular
neurotransmitter transporter combined with the respective
postsynaptic scaffold protein (VGAT with gephyrin for
inhibitory synapses, VGluT2 with PSD95 for excitatory
synapses). A day/night reorganization of the balance between
excitatory and inhibitory inputs to orexin cell bodies was
observed, without a variation of their total number, with a
predominance of inhibitory synapses during the day (about 75%)
and a predominance of excitatory synapses during the night
(about 70%) (Figure 2).
This set of data requires implementation. From the behavioral
point of view, although the sleep and wake percentages in the
hours preceding sacrifice showed very little interindividual
variability in matched animals, vigilance state needs to
be characterized in the same animals, and videorecording
experiments are currently ongoing to this purpose. Furthermore,
experiments under constant darkness need to be performed to
verify an endogenous oscillation.
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FIGURE 2 | Diurnal remodeling of the excitatory/inhibitory input to orexin cell bodies. Schematic representation of synaptic organization (excitatory/inhibitory balance)
during the light period (A) and the period of darkness (B), based on the results by Laperchia et al. (2017) in mice. Zeitgeber time (ZT) 0 corresponds to the lights-on
time. During the day (A) there was a prevalence of inhibitory synapses (blue boutons), as determined by immunopositivity to the presynaptic vesicular GABA
transporter (VGAT) and postsynaptic gephyrin, when matched mice spent most of this time asleep (slow wave sleep, SWS, and paradoxical sleep, PS), as depicted
by the apple-pie chart. An opposite arrangement was found during the night, when excitatory synapses (red boutons), as determined by immunopositivity to the
presynaptic vesicular glutamate transporter (VGluT)2 and postsynaptic density protein 95 (PSD95), prevailed, and matched mice spent most of this period awake.
At the subcellular level, excitatory and inhibitory inputs onto
orexin neuron dendrites in the same paradigm remain to be
examined. It should, however, be considered that the neuronal
soma is the site of integration of all inputs and is a critical domain
given the proximity to the site of action potential generation
(Spruston, 2008).
At the synaptic level, electron microscopy is the gold
standard for the visualization of synapses. Furthermore,
although the contact with the postsynaptic scaffolding protein
indicates a functional synapse (Wouterlood et al., 2003, 2007;
Henny and Jones, 2006; Toossi et al., 2012), morphological
approaches cannot definitely ascertain whether synaptic
contacts are functional. It should also be considered that
VGluT2 and VGAT do not visualize terminals releasing other
neurotransmitters, such as cholinergic ones. Concerning
GABAergic input, VGAT is the transporter for both GABA
and glycine (Wojcik et al., 2006), but, as mentioned previously,
VGAT is not expressed by all GABAergic terminals which
contact orexin neurons, and, in particular, is not expressed by
MCH terminals.
Even considering these limitations, the above findings
in mice show a time-of-day-dependent fluctuation in
the perisomatic innervation of orexin neurons, and
indicate a relationship of this process with sleep and wake
predominance.
WHICH MECHANISM/S FOR DIURNAL
REGULATION OF OREXIN NEURONS?
Circadian and Homeostatic Regulation
Physiological functions are regulated by the strict interplay
between the need of maintain an internal milieu (Bernard, 1865)
and the need to anticipate the fluctuations of the external
environment. The two main actors of this balance are the
homeostatic process, by which physiological variables are
regulated to remain near a defined value over time (Cannon,
1929), and circadian regulation (Halberg et al., 1959) that favors
changes for an optimal functioning at the proper time of the day.
The interaction between circadian and homeostatic components
determines the timing of sleep and wake according to the
influential “two-process model” (Borbély, 1982; Borbély et al.,
2016). In both humans and animals, a prolonged period of
wakefulness exerts a greater sleep pressure and longer and deeper
episodes of the subsequent sleep (homeostatic component,
process S). On the other side, the circadian component (process
C) is independent from sleep and wake duration and defines the
daily fluctuation of sleep propensity.
Evidence points to the daily fluctuation of orexin level in
the CSF as an endogenous rhythm: this fluctuation was robustly
maintained in rats entrained under dim red light (Deboer et al.,
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2004) as well as under constant light or constant darkness
(Zhang et al., 2004). As the other endogenous rhythms, this
orexin fluctuation in mammals is under the control of the master
circadian pacemaker, the SCN. Lesions of the SCN abolish the
daily fluctuation of CSF orexin level in rats under different
light exposure conditions (Deboer et al., 2004; Zhang et al.,
2004).
Concerning the complex issue of the relationships between
orexin neurons and the biological clock, anterograde tracing
data have suggested a polysynaptic link of the SCN with orexin
neurons (Deurveilher and Semba, 2005), consistently with other
polysynaptic SCN efferent pathways (Saper et al., 2005). As
for the reciprocal connectivity, initial mapping showed a dense
orexin-immunoreactive terminal field around, but not within,
the SCN (Peyron et al., 1998) but direct orexin innervation
of the SCN has then been shown (Belle et al., 2014). As also
mentioned previously, orexin exerts a suppression on SCN
activity, which shows a diurnal fluctuation, with predominantly
GABA-mediated presynaptic actions during the day which switch
to direct postsynaptic effects during the night (Belle et al.,
2014).
Interestingly, findings on orexin level in the CSF of rats after
different manipulations (Yoshida et al., 2001; Deboer et al., 2004)
have indicated that the SCN is not the only component that
regulates orexin fluctuation, which should therefore involve also
a homeostatic process.
In zebrafish, the above-mentioned data indicate that orexin
activity, release and synaptic re-arrangement are controlled
by both circadian and homeostatic components. Homeostatic
mechanisms have also been implicated in Fos expression in
orexin neurons after sleep deprivation and sleep recovery in rats
(Modirrousta et al., 2005), and in the expression of the subunit
α1 of GABAA receptor (GABAAR) in orexin cell bodies after
sleep deprivation in mice, confirmed by in vitro electrophysiology
(Matsuki et al., 2015). Similarly, the expression and density of
both GABAAR and GABABR on orexin neurons strongly increase
in mice after sleep deprivation and return to baseline during sleep
recovery (Toossi et al., 2016). Increase in the activity of orexin
neurons during the dark period in mice (Modirrousta et al.,
2005) results in up-regulation of GABARs on orexin neurons
(Toossi et al., 2016), facilitating their inhibition according to
the homeostatic regulation of synaptic plasticity (Turrigiano,
1999). It thus seems that the interplay between circadian and
homeostatic processes plays a pivotal role in the daily fluctuation
of the orexin system.
As also mentioned previously, the contribution of wakefulness
per se versus locomotor activity has been discussed in several
paradigms. Some lines of evidence point indeed to a correlation
of orexin activity with locomotor activity. Pivotal experiments
showed that intracerebroventricular injection of exogenous
orexin in rats increases locomotor activity (Hagan et al., 1999;
Ida et al., 1999; Piper et al., 2000), but did not disentangle
whether this is a direct effect of locomotion or a secondary
effect due to increased wakefulness. The amount of locomotor
activity rather than wakefulness has been related to orexin levels
in different sets of experiments in rats and dogs (Wu et al., 2002;
Martins et al., 2004; Zhang et al., 2004). However, experiments in
squirrel monkeys have indicated that locomotion is not necessary
for the daily fluctuation of CSF orexin levels (Zeitzer et al.,
2004).
It should also be considered that it is very demanding to clearly
dissociate the influences of locomotor activity and wakefulness,
since motor activity occurs especially during wakefulness.
Overall, however, this distinction may not be necessary since,
on the basis of their links with sleep-wake-regulatory as well
as premotor and motor centers, orexin neurons may control
both wakefulness and locomotor activity in a coordinated
manner.
Multiple Players in the
“Chronoconnectivity” of Orexin Neurons?
Synaptic mechanisms for a time-of-day dependent and sleep-
wake-related daily remodeling could involve different signaling
pathways and multiple elements.
Among chemical regulators potentially involved in
the functional “chronoconnectivity” of orexin neurons,
endocannabinoids and hormones are likely to play a role.
Endocannabinoids are emerging as master players of fast
(i.e., non-genomic) and energy-related fine-tuning of synaptic
inputs to orexin neurons, depending on CB1 expression
at glutamatergic or GABAergic terminals. In this scenario,
fasting-related reduction of leptin levels seems to control
arousal by increasing the activity of orexin neurons, which
are innervated by CB1-expressing excitatory inputs, and are a
main source of the endocannabinoid 2-arachidonoylglycerol
(Huang et al., 2007). Supporting endocannabinoid-regulated
activity of orexin release, a positive correlation has been
described in healthy humans between the circadian rhythm
of 2-arachidonoylglycerol serum level and sleep timing or
caloric intake (Hanlon et al., 2015, 2016; Cedernaes et al.,
2016). Circulating hormones such as leptin and ghrelin, which
regulate metabolism and, as mentioned previously, influence
orexin neuron activity also through neural pathways, are under
circadian regulation (Challet, 2015). Circadian rhythms of
synaptic morphology can be regulated by hormonal release
(Frank, 2016).
“Chronoconnectivity” of orexin neuron wiring could
potentially involve a timing-related regulation of neurons
capable of glutamate and GABA co-release. This has not been
examined in sources of orexin neuron innervation, but co-release
of these fast neurotransmitters has been reported at other sites
(Beltrán and Gutiérrez, 2012; Shabel et al., 2014; Ntamati and
Lüscher, 2016; Galván and Gutiérrez, 2017).
Coexistence of VGAT and VGluT1 or VGluT2 has been
reported in the hypothalamic periventricular nucleus (Ottem,
2004), hippocampal dentate gyrus (Boulland et al., 2009) and
neocortex (Fattorini et al., 2009), and it has been shown in
immunoisolated synaptic vesicles that VGAT can transport
glutamate besides GABA (Zander et al., 2010). However,
synaptophysin and VGAT expression in synaptic vesicles in
the brain does not undergo a circadian oscillation, while
VGluT2 seems to be rearranged at the synaptic level during
24 h, but without variation of the overall expression in
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presynaptic terminals (Darna et al., 2009). It also remains that
the inhibitory or excitatory synaptic phenotype is determined
by postsynaptic scaffolding proteins besides the marker/s
of presynaptic release. In this context, activity-dependent
plasticity of gephyrin at GABAergic synapses has been reported
(Flores et al., 2015). Furthermore, neuronal plasticity can be
regulated by circadian rhythms of cytoskeletal components (e.g.,
Petsakou et al., 2015).
Considering synaptic components besides the pre- and
post-synaptic elements, it is now known that perisynaptic
astrocytic sheaths are important local players, which has
led to the concept of a tripartite synapse (Araque et al.,
1999) and that extracellular matrix (ECM) structures interact
with neuronal and glial synaptic components, which has led
to the concept of a quadripartite synapse (Dityatev et al.,
2010).
Astrocytes take part in the local network of regulation
of orexin neuron activity within the LH (Burt et al., 2011).
Knock-out of connexin-43 gap junction subunits in astrocytes
throughout the brain led to the silencing of orexin neurons,
thereby causing excessive sleepiness and fragmented wakefulness
(Clasadonte et al., 2017). Modulation and negative feedback
regulation of excitatory glutamatergic inputs and the release
of astrocyte-derived factors, such as lactate and adenosine
triphosphate (ATP), can affect the excitability of orexin neurons.
It has been shown that ATP release from cultured astrocytes
is under circadian control (Marpegan et al., 2011). Orexin
neurons utilize lactate derived from astrocytes as energy
substrate (Parsons and Hirasawa, 2011), and glutamatergic
transmission has been proposed to stimulate orexin neurons
via the astrocyte-neuron lactate shuttle mediated through
monocarboxylate transporters (Burt et al., 2011). This role
of astrocytes as energy substrate is critical for the activity
of orexin neurons. Perisomatic appositions expressing
glutamate transporter 1, the main astrocytic transporter
which plays a key role in glutamatergic transmission,
decrease around orexin neurons and increase around MCH
neurons after sleep deprivation in the rat (Briggs et al.,
2018).
In their surveillance function, microglial cells continuously
extend and retract their branches, contacting also synapses
(Miyamoto et al., 2013). Diurnal changes of the overall extent
of microglial branches have been observed in the cerebral
cortex of mice in basal conditions (Hayashi et al., 2013b).
Investigations on the molecular mechanisms underlying the
diurnal morphological changes of cortical microglia have
pointed out a regulation by clock genes (Hayashi et al.,
2013a,b) and therefore an “intrinsic microglial molecular
clock” (Hayashi et al., 2013a). This was found to drive
the circadian expression of cathepsin S, a microglia-specific
protease which degrades ECM molecules (Hayashi et al.,
2013a), thus implicating ECM components in the extension
and retraction of microglial cell processes at different times of
the day.
On the other hand, ECM components are main players in
synaptic plasticity phenomena, not only during development but
also in the adult brain (Dityatev et al., 2010; Song and Dityatev,
2017; Ferrer-Ferrer and Dityatev, 2018). The organization of
the ECM has been investigated in the anterior hypothalamus
(Horii-Hayashi et al., 2017) but remains to be investigated in
the LH.
Overall, diurnal changes of glial cells and ECM in the LH in
basal conditions await for further studies, which could reveal in
this region an orchestra of multiple elements engaged in synaptic
remodeling.
CONCLUDING REMARKS
The data here reviewed point to a daily fluctuation of
excitatory and inhibitory inputs to orexin neurons as a
feature of the logic of this vast network to face dynamic
physiological demands. This envisages a “chronoconnectivity”
which may involve different sets of inputs and may underlie
diurnal fluctuation of neuronal firing and overall neuron
activity.
Such conceptual framework is different from the synaptic
homeostasis processes hypothesized during sleep and wake
(Tononi and Cirelli, 2003, 2014). The synaptic homeostasis
hypothesis is centered on the variation of synaptic strength
leading to synaptic potentiation during wake and synaptic
depression during sleep (Tononi and Cirelli, 2003, 2014),
but does not involve neuronal firing rates (Cirelli, 2017).
Synaptic homeostatic changes during sleep and wake could
be subserved by circadian synaptic changes, as observed in
synaptic morphology in the somatosensory cortex (Jasinska
et al., 2015), and in the size of cortical dendritic spines and
area of axon-spine interface during sleep and wake (De Vivo
et al., 2017). “Chronoconnectivity” implies instead time of day-
dependent and sleep-wake-dependent fluctuation of firing rate
and connectivity. In the wiring of orexin neurons, this could
involve extra- and intra-hypothalamic mechanisms which remain
to be elucidated.
Of note, changes of neuronal firing in different phases of
the sleep-wake cycle is a property of many cell groups in
the distributed network of sleep-wake regulation (Scammell
et al., 2017), as also highlighted by optogenetic studies
(Tyree and de Lecea, 2017). The question thus arises: could
neuron wiring fluctuation represent a general property of this
network?
AUTHOR CONTRIBUTIONS
IA wrote the first draft of the manuscript. FDG
and LC contributed to various parts of the text and
FDG prepared the figures. MB contributed to the
theoretical framework and prepared the final manuscript
version.
FUNDING
The preparation of this manuscript was supported by intramural
funds.
Frontiers in Pharmacology | www.frontiersin.org 11 September 2018 | Volume 9 | Article 1061
fphar-09-01061 September 22, 2018 Time: 15:4 # 12
Azeez et al. Daily Fluctuation of Orexin Neuron Wiring
REFERENCES
Abrahamson, E. E., Leak, R. K., and Moore, R. Y. (2001). The suprachiasmatic
nucleus projects to posterior hypothalamic arousal systems. Neuroreport 12,
435–440. doi: 10.1097/00001756-200102120-00048
Adamantidis, A., and de Lecea, L. (2009). A role for melanin-concentrating
hormone in learning and memory. Peptides 30, 2066–2070. doi: 10.1016/j.
peptides.2009.06.024
Adamantidis, A. R., Zhang, F., Aravanis, A. M., Deisseroth, K., and de Lecea, L.
(2007). Neural substrates of awakening probed with optogenetic control of
hypocretin neurons. Nature 450, 420–424. doi: 10.1038/nature06310
Agostinelli, L. J., Ferrari, L. L., Mahoney, C. E., Mochizuki, T., Lowell, B. B.,
Arrigoni, E., et al. (2017). Descending projections from the basal forebrain to
the orexin neurons in mice. J. Comp. Neurol. 525, 1668–1684. doi: 10.1002/cne.
24158
Aitta-Aho, T., Pappa, E., Burdakov, D., and Apergis-Schoute, J. (2016). Cellular
activation of hypothalamic hypocretin/orexin neurons facilitates short-term
spatial memory in mice. Neurobiol. Learn. Mem. 136, 183–188. doi: 10.1016/
j.nlm.2016.10.005
Apergis-Schoute, J., Iordanidou, P., Faure, C., Jego, S., Schone, C., Aitta-Aho, T.,
et al. (2015). Optogenetic evidence for inhibitory signaling from orexin to
MCH neurons via local microcircuits. J. Neurosci. 35, 5435–5441. doi: 10.1523/
JNEUROSCI.5269-14.2015
Appelbaum, L., Wang, G., Yokogawa, T., Skariah, G. M., Smith, S. J., Mourrain, P.,
et al. (2010). Circadian and homeostatic regulation of structural synaptic
plasticity in hypocretin neurons. Neuron 68, 87–98. doi: 10.1016/j.neuron.2010.
09.006
Appelbaum, L., Wang, G. X., Maro, G. S., Mori, R., Tovin, A., Marin, W.,
et al. (2009). Sleep-wake regulation and hypocretin-melatonin interaction in
zebrafish. Proc. Natl. Acad. Sci. U.S.A. 106, 21942–21947. doi: 10.1073/pnas.
906637106
Araque, A., Parpura, V., Sanzgiri, R. P., and Haydon, P. G. (1999). Tripartite
synapses: glia, the unacknowledged partner. Trends Neurosci. 22, 208–215.
doi: 10.1016/S0166-2236(98)01349-6
Baimel, C., Bartlett, S. E., Chiou, L. C., Lawrence, A. J., Muschamp, J. W., Patkar, O.,
et al. (2015). Orexin/hypocretin role in reward: implications for opioid and
other addictions. Br. J. Pharmacol. 172, 334–348. doi: 10.1111/bph.12639
Bayer, L., Mairet-Coello, G., Risold, P. Y., and Griffond, B. (2002).
Orexin/hypocretin neurons: chemical phenotype and possible interactions
with melanin-concentrating hormone neurons. Regul. Pept. 104, 33–39.
doi: 10.1016/S0167-0115(01)00320-2
Becker, T. M., Favero, M., Di Marzo, V., Cristino, L., and Busetto, G.
(2017). Endocannabinoid-dependent disinhibition of orexinergic neurons:
electrophysiological evidence in leptin-knockout obese mice. Mol. Metab. 6,
594–601. doi: 10.1016/j.molmet.2017.04.005
Belle, M. D. C., Hughes, A. T. L., Bechtold, D. A., Cunningham, P., Pierucci, M.,
Burdakov, D., et al. (2014). Acute suppressive and long-term phase modulation
actions of orexin on the mammalian circadian clock. J. Neurosci. 34, 3607–3621.
doi: 10.1523/JNEUROSCI.3388-13.2014
Beltrán, J. Q., and Gutiérrez, R. (2012). Co-release of glutamate and GABA from
single, identified mossy fibre giant boutons. J. Physiol. 590, 4789–4800. doi:
10.1113/jphysiol.2012.236372
Bernard, C. (1865). Introduction à l’étude de la médecine expérimentale. Rev. Des
Cours Sci. Paris. 22, 157–161. doi: 10.1522/cla.bec.int
Bittencourt, J. C. (2011). Anatomical organization of the melanin-concentrating
hormone peptide family in the mammalian brain. Gen. Comp. Endocrinol. 172,
185–197. doi: 10.1016/j.ygcen.2011.03.028
Blanco-Centurion, C., Bendell, E., Zou, B., Sun, Y., Shiromani, P. J., and Liu, M.
(2018). VGAT and VGLUT2 expression in MCH and orexin neurons in
double transgenic reporter mice. IBRO Rep. 4, 44–49. doi: 10.1016/j.ibror.2018.
05.001
Blanco-Centurion, C., Liu, M., Konadhode, R. P., Zhang, X., Pelluru, D., van
den Pol, A. N., et al. (2016). Optogenetic activation of melanin-concentrating
hormone neurons increases non-rapid eye movement and rapid eye movement
sleep during the night in rats. Eur. J. Neurosci. 44, 2846–2857. doi: 10.1111/ejn.
13410
Blouin, A. M., Fried, I., Wilson, C. L., Staba, R. J., Behnke, E. J., Lam, H. A.,
et al. (2013). Human hypocretin and melanin-concentrating hormone levels are
linked to emotion and social interaction. Nat. Commun. 4:1547. doi: 10.1038/
ncomms2461
Boddum, K., Hansen, M. H., Jennum, P. J., and Kornum, B. R. (2016).
Cerebrospinal fluid hypocretin-1 (orexin-A) level fluctuates with season and
correlates with day length. PLoS One 11:e0151288. doi: 10.1371/journal.pone.
0151288
Bonnavion, P., Mickelsen, L. E., Fujita, A., de Lecea, L., and Jackson, A. C. (2016).
Hubs and spokes of the lateral hypothalamus: cell types, circuits and behaviour.
J. Physiol. 594, 6443–6462. doi: 10.1113/JP271946
Borbély, A. A. (1982). A two process model of sleep regulation. Hum. Neurobiol. 1,
195–204. doi: 10.1111/jsr.12371
Borbély, A. A., Daan, S., Wirz-Justice, A., and Deboer, T. (2016). The two-process
model of sleep regulation: a reappraisal. J. Sleep Res. 25, 131–143. doi: 10.1111/
jsr.12371
Boulland, J. L., Jenstad, M., Boekel, A. J., Wouterlood, F. G., Edwards, R. H., Storm-
Mathisen, J., et al. (2009). Vesicular glutamate and GABA transporters sort to
distinct sets of vesicles in a population of presynaptic terminals. Cereb. Cortex
19, 241–248. doi: 10.1093/cercor/bhn077
Briggs, C., Hirasawa, M., and Semba, K. (2018). Sleep deprivation distinctly alters
glutamate transporter 1 apposition and excitatory transmission to orexin and
MCH neurons. J. Neurosci. 38, 2179–2217. doi: 10.1523/JNEUROSCI.2179-17.
2018
Bubser, M., Fadel, J. R., Jackson, L. L., Meador-Woodruff, J. H., Jing, D., and
Deutch, A. Y. (2005). Dopaminergic regulation of orexin neurons. Eur. J.
Neurosci. 21, 2993–3001. doi: 10.1111/j.1460-9568.2005.04121.x
Burt, J., Alberto, C. O., Parsons, M. P., and Hirasawa, M. (2011). Local network
regulation of orexin neurons in the lateral hypothalamus. Am. J. Physiol. Regul.
Integr. Comp. Physiol. 301, R572–R580. doi: 10.1152/ajpregu.00674.2010
Cannon, W. B. (1929). Organization for physiological homeostasis. Physiol. Rev. 9,
399–431. doi: 10.1152/physrev.1929.9.3.399
Cedernaes, J., Fanelli, F., Fazzini, A., Pagotto, U., Broman, J. E., Vogel, H.,
et al. (2016). Sleep restriction alters plasma endocannabinoids concentrations
before but not after exercise in humans. Psychoneuroendocrinology 74, 258–268.
doi: 10.1016/j.psyneuen.2016.09.014
Challet, E. (2015). Keeping circadian time with hormones. Diabetes Obes. Metab.
17(Suppl. 1), 76–83. doi: 10.1111/dom.12516
Chemelli, R. M., Willie, J. T., Sinton, C. M., Elmquist, J. K., Scammell, T.,
Lee, C., et al. (1999). Narcolepsy in orexin knockout mice: molecular
genetics of sleep regulation. Cell 98, 437–451. doi: 10.1016/S0092-8674(00)
81973-X
Chou, T. C., Lee, C. E., Lu, J., Elmquist, J. K., Hara, J., Willie, J. T., et al. (2001).
Orexin (hypocretin) neurons contain dynorphin. J. Neurosci. 21:RC168. doi:
10.1523/JNEUROSCI.21-19-j0003.2001
Cirelli, C. (2017). Sleep, synaptic homeostasis and neuronal firing rates. Curr. Opin.
Neurobiol. 44, 72–79. doi: 10.1016/j.conb.2017.03.016
Cirelli, C., Pompeiano, M., and Tononi, G. (1995). Sleep deprivation and c-fos
expression in the rat brain. J. Sleep Res. 4, 92–106. doi: 10.1111/j.1365-2869.
1995.tb00157.x
Clasadonte, J., Scemes, E., Wang, Z., Boison, D., and Haydon, P. G. (2017).
Connexin 43-mediated astroglial metabolic networks contribute to the
regulation of the sleep-wake cycle. Neuron 95, 1365.e5–1380.e51380. doi: 10.
1016/j.neuron.2017.08.022
Colavito, V., Tesoriero, C., Wirtu, A. T., Grassi-Zucconi, G., and Bentivoglio, M.
(2015). Limbic thalamus and state-dependent behavior: the paraventricular
nucleus of the thalamic midline as a node in circadian timing and sleep/wake-
regulatory networks. Neurosci. Biobehav. Rev. 54, 3–17. doi: 10.1016/j.
neubiorev.2014.11.021
Cristino, L., Busetto, G., Imperatore, R., Ferrandino, I., Palomba, L., Silvestri, C.,
et al. (2013). Obesity-driven synaptic remodeling affects endocannabinoid
control of orexinergic neurons. Proc. Natl. Acad. Sci. U.S.A. 110, E2229–E2238.
doi: 10.1073/pnas.1219485110
Cristino, L., Luongo, L., Imperatore, R., Boccella, S., Becker, T., Morello, G.,
et al. (2016). Orexin-A and endocannabinoid activation of the descending
antinociceptive pathway underlies altered pain perception in leptin signaling
deficiency. Neuropsychopharmacology 41, 508–520. doi: 10.1038/npp.
2015.173
Darna, M., Schmutz, I., Richter, K., Yelamanchili, S. V., Pendyala, G., Höltje, M.,
et al. (2009). Time of day-dependent sorting of the vesicular glutamate
Frontiers in Pharmacology | www.frontiersin.org 12 September 2018 | Volume 9 | Article 1061
fphar-09-01061 September 22, 2018 Time: 15:4 # 13
Azeez et al. Daily Fluctuation of Orexin Neuron Wiring
transporter to the plasma membrane. J. Biol. Chem. 284, 4300–4307. doi: 10.
1074/jbc.M805480200
de Lecea, L., Kilduff, T. S., Peyron, C., Gao, X.-B., Foye, P. E., Danielson, P. E., et al.
(1998). The hypocretins: hypothalamus-specific peptides with neuroexcitatory
activity. Proc. Natl. Acad. Sci. U.S.A. 95, 322–327. doi: 10.1073/pnas.95.1.322
De Vivo, L., Bellesi, M., Marshall, W., Bushong, E. A., Ellisman, M. H., Tononi, G.,
et al. (2017). Ultrastructural evidence for synaptic scaling across the wake/sleep
cycle. Science 355, 507–510. doi: 10.1126/science.aah5982
Deboer, T., Overeem, S., Visser, N. A. H., Duindam, H., Frölich, M., Lammers,
G. J., et al. (2004). Convergence of circadian and sleep regulatory mechanisms
on hypocretin-1. Neuroscience 129, 727–732. doi: 10.1016/j.neuroscience.2004.
07.049
Desarnaud, F., Murillo-Rodriguez, E., Lin, L., Xu, M., Gerashchenko, D.,
Shiromani, S. N., et al. (2004). The diurnal rhythm of hypocretin in young and
old F344 rats. Sleep 27, 851–856. doi: 10.1093/sleep/27.5.851
Deurveilher, S., and Semba, K. (2005). Indirect projections from the
suprachiasmatic nucleus to major arousal-promoting cell groups in rat:
implications for the circadian control of behavioural state. Neuroscience 130,
165–183. doi: 10.1016/j.neuroscience.2004.08.030
Dityatev, A., Seidenbecher, C. I., and Schachner, M. (2010). Compartmentalization
from the outside: the extracellular matrix and functional microdomains in the
brain. Trends Neurosci. 33, 503–512. doi: 10.1016/j.tins.2010.08.003
Elbaz, I., Foulkes, N. S., Gothilf, Y., and Appelbaum, L. (2013). Circadian clocks,
rhythmic synaptic plasticity and the sleep-wake cycle in zebrafish. Front. Neural
Circuits 7:9. doi: 10.3389/fncir.2013.00009
Elbaz, I., Levitas-Djerbi, T., and Appelbaum, L. (2017). The hypocretin/orexin
neuronal networks in zebrafish. Curr. Top. Behav. Neurosci. 33, 75–92.
doi: 10.1007/7854_2016_59
Eriksson, K. S., Sergeeva, O., Brown, R. E., and Haas, H. L. (2001).
Orexin/hypocretin excites the histaminergic neurons of the tuberomammillary
nucleus. J. Neurosci. 21, 9273–9279. doi: 10.1523/JNEUROSCI.21-23-09273.
2001
España, R. A., Valentino, R. J., and Berridge, C. W. (2003). Fos immunoreactivity
in hypocretin-synthesizing and hypocretin-1 receptor-expressing neurons:
effects of diurnal and nocturnal spontaneous waking, stress and hypocretin-
1 administration. Neuroscience 121, 201–217. doi: 10.1016/S0306-4522(03)
00334-8
Estabrooke, I. V., Mccarthy, M. T., Ko, E., Chou, T. C., Chemelli, R. M.,
Yanagisawa, M., et al. (2001). Fos expression in orexin neurons varies with
behavioral state. J. Neurosci. 21, 1656–1662. doi: 10.1152/jn.00927.2005
Fattorini, G., Verderio, C., Melone, M., Giovedì, S., Benfenati, F., Matteoli, M.,
et al. (2009). VGLUT1 and VGAT are sorted to the same population of synaptic
vesicles in subsets of cortical axon terminals. J. Neurochem. 110, 1538–1546.
doi: 10.1111/j.1471-4159.2009.06251.x
Ferrari, L. L., Park, D., Zhu, L., Palmer, M. R., Broadhurst, R. Y., and Arrigoni, E.
(2018). Regulation of lateral hypothalamic orexin activity by local GABAergic
neurons. J. Neurosci. 38, 1588–1599. doi: 10.1523/JNEUROSCI.1925-17.2017
Ferreira, J. G. P., Bittencourt, J. C., and Adamantidis, A. (2017). Melanin-
concentrating hormone and sleep. Curr. Opin. Neurobiol. 44, 152–158.
doi: 10.1016/J.CONB.2017.04.008
Ferrer-Ferrer, M., and Dityatev, A. (2018). Shaping synapses by the neural
extracellular matrix. Front. Neuroanat. 12:40. doi: 10.3389/fnana.2018.00040
Flores, Á., Valls-Comamala, V., Costa, G., Saravia, R., Maldonado, R., and
Berrendero, F. (2014). The hypocretin/orexin system mediates the extinction
of fear memories. Neuropsychopharmacology 39, 2732–2741. doi: 10.1038/npp.
2014.146
Flores, C. E., Nikonenko, I., Mendez, P., Fritschy, J.-M., Tyagarajan, S. K.,
and Muller, D. (2015). Activity-dependent inhibitory synapse remodeling
through gephyrin phosphorylation. Proc. Natl. Acad. Sci. U.S.A. 112, E65–E72.
doi: 10.1073/pnas.1411170112
Frank, M. (2016). Circadian regulation of synaptic plasticity. Biology 5:31.
doi: 10.3390/biology5030031
Fujiki, N., Yoshida, Y., Ripley, B., Honda, K., Mignot, E., and Nishino, S. (2001).
Changes in CSF hypocretin-1 (orexin A) levels in rats across 24 hours and in
response to food deprivation. Neuroreport 12, 993–997. doi: 10.1097/00001756-
200104170-00026
Furutani, N., Hondo, M., Kageyama, H., Tsujino, N., Mieda, M., Yanagisawa, M.,
et al. (2013). Neurotensin co-expressed in orexin-producing neurons
in the lateral hypothalamus plays an important role in regulation of
sleep/wakefulness states. PLoS One 8:e62391. doi: 10.1371/journal.pone.
0062391
Galván, E. J., and Gutiérrez, R. (2017). Target-dependent compartmentalization of
the corelease of glutamate and GABA from the mossy fibers. J. Neurosci. 37,
701–714. doi: 10.1523/JNEUROSCI.1915-16.2016
Gerashchenko, D., and Shiromani, P. J. (2004). Different neuronal phenotypes
in the lateral hypothalamus and their role in sleep and wakefulness. Mol.
Neurobiol. 29, 41–59. doi: 10.1385/MN
Gerstner, J. R., Vander Heyden, W. M., LaVaute, T. M., and Landry, C. F. (2006).
Profiles of novel diurnally regulated genes in mouse hypothalamus: expression
analysis of the cysteine and histidine-rich domain-containing, zinc-binding
protein 1, the fatty acid-binding protein 7 and the GTPase, Ras-like family
member 11b. Neuroscience 139, 1435–1448. doi: 10.1016/j.neuroscience.2006.
01.020
Giardino, W. J., and de Lecea, L. (2014). Hypocretin (orexin) neuromodulation of
stress and reward pathways. Curr. Opin. Neurobiol. 29, 103–108. doi: 10.1016/j.
conb.2014.07.006
González, J. A., Iordanidou, P., Strom, M., Adamantidis, A., and Burdakov, D.
(2016). Awake dynamics and brain-wide direct inputs of hypothalamic
MCH and orexin networks. Nat. Commun. 7:11395. doi: 10.1038/ncomm
s11395
Grady, S. P., Nishino, S., Czeisler, C. A., Hepner, D., and Scammell, T. E. (2006).
Diurnal variation in CSF orexin-A in healthy male subjects. Sleep 29, 295–297.
doi: 10.1093/sleep/29.3.295
Grassi-Zucconi, G., Giuditta, A., Mandile, P., Chen, S., Vescia, S., and
Bentivoglio, M. (1994). c-fos spontaneous expression during wakefulness is
reversed during sleep in neuronal subsets of the rat cortex. J. Physiol. Paris 88,
91–93. doi: 10.1016/0928-4257(94)90096-5
Grassi-Zucconi, G., Menegazzi, M., De Prati, A. C., Bassetti, A., Montagnese, P.,
Mandile, P., et al. (1993). c-fos mRNA is spontaneously induced in the rat brain
during the activity period of the circadian cycle. Eur. J. Neurosci. 5, 1071–1078.
doi: 10.1111/j.1460-9568.1993.tb00960.x
Guan, J. L., Uehara, K., Lu, S., Wang, Q. P., Funahashi, H., Sakurai, T., et al. (2002).
Reciprocal synaptic relationships between orexin- and melanin-concentrating
hormone-containing neurons in the rat lateral hypothalamus: a novel circuit
implicated in feeding regulation. Int. J. Obes. 26, 1523–1532. doi: 10.1038/sj.ijo.
0802155
Guyon, A., Conductier, G., Rovere, C., Enfissi, A., and Nahon, J. L. (2009). Melanin-
concentrating hormone producing neurons: activities and modulations.
Peptides 30, 2031–2039. doi: 10.1016/j.peptides.2009.05.028
Hagan, J. J., Leslie, R. A., Patel, S., Evans, M. L., Wattam, T. A., Holmes, S., et al.
(1999). Orexin A activates locus coeruleus cell firing and increases arousal in
the rat. Proc. Natl. Acad. Sci. U. S. A. 96, 10911–10916. doi: 10.1073/PNAS.96.
19.10911
Halberg, F., Halberg, E., and Barnum, C. P. (1959). Physiologic 24-hour periodicity
in human beings and mice, the lighting regimen and daily routine. Photoperiod.
Relat. Phenom. plants Anim. 55, 803–878.
Hanlon, E. C., Tasali, E., Leproult, R., Stuhr, K. L., Doncheck, E., de Wit, H.,
et al. (2015). Circadian rhythm of circulating levels of the endocannabinoid 2-
arachidonoylglycerol. J. Clin. Endocrinol. Metab. 100, 220–226. doi: 10.1210/jc.
2014-3455
Hanlon, E. C., Tasali, E., Leproult, R., Stuhr, K. L., Doncheck, E., de Wit, H.,
et al. (2016). Sleep restriction enhances the daily rhythm of circulating levels
of endocannabinoid 2-arachidonoylglycerol. Sleep 39, 653–664. doi: 10.5665/
sleep.5546
Hassani, O. K., Lee, M. G., and Jones, B. E. (2009). Melanin-concentrating hormone
neurons discharge in a reciprocal manner to orexin neurons across the sleep-
wake cycle. Proc. Natl. Acad. Sci. U.S.A. 106, 2418–2422. doi: 10.1073/pnas.
0811400106
Hayashi, Y., Koyanagi, S., Kusunose, N., Okada, R., Wu, Z., Tozaki-Saitoh, H., et al.
(2013a). The intrinsic microglial molecular clock controls synaptic strength
via the circadian expression of cathepsin S. Sci. Rep. 3:2744. doi: 10.1038/
srep02744
Hayashi, Y., Koyanagi, S., Kusunose, N., Takayama, F., Okada, R., Wu, Z., et al.
(2013b). Diurnal spatial rearrangement of microglial processes through the
rhythmic expression of P2Y12 receptors. J. Neurol. Disord. 01:120. doi: 10.4172/
2329-6895.1000120
Frontiers in Pharmacology | www.frontiersin.org 13 September 2018 | Volume 9 | Article 1061
fphar-09-01061 September 22, 2018 Time: 15:4 # 14
Azeez et al. Daily Fluctuation of Orexin Neuron Wiring
Henny, P., and Jones, B. E. (2006). Innervation of orexin/hypocretin neurons by
GABAergic, glutamatergic or cholinergic basal forebrain terminals evidenced
by immunostaining for presynaptic vesicular transporter and postsynaptic
scaffolding proteins. J. Comp. Neurol. 499, 645–661. doi: 10.1002/cne.
21131
Herdegen, T., and Leah, J. D. (1998). Inducible and constitutive transcription
factors in the mammalian nervous system: control of gene expression by Jun,
Fos and Krox, and CREB/ATF proteins. Brain Res. Rev. 28, 370–490. doi: 10.
1016/S0165-0173(98)00018-6
Herrera, C. G., Ponomarenko, A., Korotkova, T., Burdakov, D., and
Adamantidis, A. (2017). Sleep & metabolism: the multitasking ability of
lateral hypothalamic inhibitory circuitries. Front. Neuroendocrinol. 44:27–34.
doi: 10.1016/J.YFRNE.2016.11.002
Ho, Y.-C., Lee, H.-J., Tung, L.-W., Liao, Y.-Y., Fu, S.-Y., Teng, S.-F., et al. (2011).
Activation of orexin 1 receptors in the periaqueductal gray of male rats leads
to antinociception via retrograde endocannabinoid (2-arachidonoylglycerol)-
induced disinhibition. J. Neurosci. 31, 14600–14610. doi: 10.1523/JNEUROSCI.
2671-11.2011
Hondo, M., Furutani, N., Yamasaki, M., Watanabe, M., and Sakurai, T. (2011).
Orexin neurons receive glycinergic innervations. PLoS One 6:e25076. doi: 10.
1371/journal.pone.0025076
Horii-Hayashi, N., Sasagawa, T., and Nishi, M. (2017). Insights from extracellular
matrix studies in the hypothalamus: structural variations of perineuronal nets
and discovering a new perifornical area of the anterior hypothalamus. Anat. Sci.
Int. 92, 18–24. doi: 10.1007/s12565-016-0375-5
Horvath, T. L., Abizaid, A., Dietrich, M. O., Li, Y., Takahashi, J. S., and Bass, J.
(2012). Ghrelin-immunopositive hypothalamic neurons tie the circadian clock
and visual system to the lateral hypothalamic arousal center. Mol. Metab. 1,
79–85. doi: 10.1016/j.molmet.2012.08.003
Horvath, T. L., and Gao, X. B. (2005). Input organization and plasticity of
hypocretin neurons. Possible clues to obesity’s association with insomnia. Cell
Metab. 1, 279–286. doi: 10.1016/j.cmet.2005.03.003
Horvath, T. L., Peyron, C., Diano, S., Ivanov, A., Aston-Jones, G., Kilduff, T. S.,
et al. (1999). Hypocretin (orexin) activation and synaptic innervation of
the locus coeruleus noradrenergic system. J. Comp. Neurol. 415, 145–159.
doi: 10.1002/(SICI)1096-9861(19991213)415:2<145::AID-CNE1>3.0.CO;2-2
Huang, H., Acuna-Goycolea, C., Li, Y., Cheng, H. M., Obrietan, K., and van den
Pol, A. N. (2007). Cannabinoids excite hypothalamic melanin-concentrating
hormone but inhibit hypocretin/orexin neurons: implications for cannabinoid
actions on food intake and cognitive arousal. J. Neurosci. 27, 4870–4881.
doi: 10.1523/JNEUROSCI.0732-07.2007
Ida, T., Nakahara, K., Katayama, T., Murakami, N., and Nakazato, M. (1999). Effect
of lateral cerebroventricular injection of the appetite- stimulating neuropeptide,
orexin and neuropeptide Y, on the various behavioral activities of rats. Brain Res.
821, 526–529. doi: 10.1016/S0006-8993(99)01131-2
Inutsuka, A., and Yamanaka, A. (2013). The regulation of sleep and wakefulness
by the hypothalamic neuropeptide orexin/hypocretin. Nagoya J. Med. Sci. 75,
29–36.
Inutsuka, A., Yamashita, A., Chowdhury, S., Nakai, J., Ohkura, M., Taguchi, T.,
et al. (2016). The integrative role of orexin/hypocretin neurons in nociceptive
perception and analgesic regulation. Sci. Rep. 6:29480. doi: 10.1038/s
rep29480
Jasinska, M., Grzegorczyk, A., Woznicka, O., Jasek, E., Kossut, M., Barbacka-
Surowiak, G., et al. (2015). Circadian rhythmicity of synapses in mouse
somatosensory cortex. Eur. J. Neurosci. 42, 2585–2594. doi: 10.1111/ejn.13045
Karnani, M. M., Szabó, G., Erdélyi, F., and Burdakov, D. (2013). Lateral
hypothalamic GAD65 neurons are spontaneously firing and distinct from
orexin- and melanin-concentrating hormone neurons. J. Physiol. 591, 933–953.
doi: 10.1113/jphysiol.2012.243493
Kastin, A. J., and Akerstrom, V. (1999). Orexin A but not orexin B rapidly enters
brain from blood by simple diffusion. J. Pharmacol. Exp. Ther. 289, 219–223.
Kiyashchenko, L. I., Mileykovskiy, B. Y., Maidment, N., Lam, H. A., Wu, M. F.,
John, J., et al. (2002). Release of hypocretin (orexin) during waking and sleep
states. J. Neurosci. 22, 5282–5286. doi: 10.1523/JNEUROSCI.22-13-05282.2002
Kodama, T., Usui, S., Honda, Y., and Kimura, M. (2005). High Fos
expression during the active phase in orexin neurons of a diurnal rodent,
Tamias sibiricus barberi. Peptides 26, 631–638. doi: 10.1016/j.peptides.2004.
11.016
Konadhode, R. R., Pelluru, D., Blanco-Centurion, C., Zayachkivsky, A., Liu, M.,
Uhde, T., et al. (2013). Optogenetic stimulation of MCH neurons increases
sleep. J. Neurosci. 33, 10257–10263. doi: 10.1523/JNEUROSCI.1225-13.
2013
Konadhode, R. R., Pelluru, D., and Shiromani, P. J. (2015). Neurons containing
orexin or melanin concentrating hormone reciprocally regulate wake and sleep.
Front. Syst. Neurosci. 8:244. doi: 10.3389/fnsys.2014.00244
Kukkonen, J. P. (2013). Physiology of the orexinergic/hypocretinergic system: a
revisit in 2012. Am. J. Phys. Cell Physiol. 304, C2–C32. doi: 10.1152/ajpcell.
00227.2012
Laperchia, C., Imperatore, R., Azeez, I. A., Del Gallo, F., Bertini, G., Grassi-
Zucconi, G., et al. (2017). The excitatory/inhibitory input to orexin/hypocretin
neuron soma undergoes day/night reorganization. Brain Struct. Funct. 222,
3847–3859. doi: 10.1007/s00429-017-1466-3
Lee, M. G., Hassani, O. K., and Jones, B. E. (2005). Discharge of identified
orexin/hypocretin neurons across the sleep-waking cycle. J. Neurosci. 25, 6716–
6720. doi: 10.1523/JNEUROSCI.1887-05.2005
Leinninger, G. M., Jo, Y. H., Leshan, R. L., Louis, G. W., Yang, H., Barrera, J. G., et al.
(2009). Leptin acts via leptin receptor-expressing lateral hypothalamic neurons
to modulate the mesolimbic dopamine system and suppress feeding.Cell Metab.
10, 89–98. doi: 10.1016/j.cmet.2009.06.011
Leinninger, G. M., Opland, D. M., Jo, Y. H., Faouzi, M., Christensen, L.,
Cappellucci, L. A., et al. (2011). Leptin action via neurotensin neurons controls
orexin, the mesolimbic dopamine system and energy balance. Cell Metab. 14,
313–323. doi: 10.1016/j.cmet.2011.06.016
Li, Y., Gao, X. B., Sakurai, T., and Van den Pol, A. N. (2002). Hypocretin/orexin
excites hypocretin neurons via a local glutamate neuron - a potential
mechanism for orchestrating the hypothalamic arousal system. Neuron 36,
1169–1181. doi: 10.1016/S0896-6273(02)01132-7
Li, Y., and van den Pol, A. N. (2005). Direct and indirect inhibition by
catecholamines of hypocretin/orexin neurons. J. Neurosci. 25, 173–183.
doi: 10.1523/JNEUROSCI.4015-04.2005
Lin, L., Faraco, J., Li, R., Kadotani, H., Rogers, W., Lin, X., et al. (1999). The sleep
disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin)
receptor 2 gene. Cell 98, 365–376. doi: 10.1016/S0092-8674(00)81965-0
Linehan, V., Fang, L. Z., and Hirasawa, M. (2018). Short-term high-fat diet primes
excitatory synapses for long-term depression in orexin neurons. J. Physiol. 596,
305–316. doi: 10.1113/JP275177
López, M., Nogueiras, R., Tena-Sempere, M., and Diéguez, C. (2010). Orexins
(hypocretins) actions on the GHRH/somatostatin-GH axis. Acta Physiol. 198,
325–334. doi: 10.1111/j.1748-1716.2009.02042.x
Louis, G. W., Leinninger, G. M., Rhodes, C. J., and Myers, M. G. (2010). Direct
innervation and modulation of orexin neurons by lateral hypothalamic LepRb
neurons. J. Neurosci. 30, 11278–11287. doi: 10.1523/JNEUROSCI.1340-10.
2010
Ma, S., Hangya, B., Leonard, C. S., Wisden, W., and Gundlach, A. L. (2018).
Dual-transmitter systems regulating arousal, attention, learning and memory.
Neurosci. Biobehav. Rev. 85, 21–33. doi: 10.1016/j.neubiorev.2017.07.009
Marcus, J. N., Aschkenasi, C. J., Lee, C. E., Chemelli, R. M., Saper, C. B.,
Yanagisawa, M., et al. (2001). Differential expression of orexin receptors 1 and
2 in the rat brain. J. Comp. Neurol. 435, 6–25. doi: 10.1002/cne.1190
Marpegan, L., Swanstrom, A. E., Chung, K., Simon, T., Haydon, P. G., Khan, S. K.,
et al. (2011). Circadian regulation of ATP release in astrocytes. J. Neurosci. 31,
8342–8350. doi: 10.1523/JNEUROSCI.6537-10.2011
Marston, O. J., Williams, R. H., Canal, M. M., Samuels, R. E., Upton, N., and
Piggins, H. D. (2008). Circadian and dark-pulse activation of orexin/hypocretin
neurons. Mol. Brain 1:19. doi: 10.1186/1756-6606-1-19
Martínez, G. S., Smale, L., and Nunez, A. A. (2002). Diurnal and nocturnal rodents
show rhythms in orexinergic neurons. Brain Res. 955, 1–7. doi: 10.1016/S0006-
8993(02)03264-X
Martins, P. J. F., D’Almeida, V., Pedrazzoli, M., Lin, L., Mignot, E., and Tufik, S.
(2004). Increased hypocretin-1 (orexin-A) levels in cerebrospinal fluid of rats
after short-term forced activity.Regul. Pept. 117, 155–158. doi: 10.1016/j.regpep.
2003.10.003
Matsuki, T., Takasu, M., Hirose, Y., Murakoshi, N., Sinton, C. M., Motoike, T.,
et al. (2015). GABAA receptor-mediated input change on orexin neurons
following sleep deprivation in mice. Neuroscience 284, 217–224. doi: 10.1016/
j.neuroscience.2014.09.063
Frontiers in Pharmacology | www.frontiersin.org 14 September 2018 | Volume 9 | Article 1061
fphar-09-01061 September 22, 2018 Time: 15:4 # 15
Azeez et al. Daily Fluctuation of Orexin Neuron Wiring
Mavanji, V., Butterick, T. A., Duffy, C. M., Nixon, J. P., Billington, C. J., and Kotz,
C. M. (2017). Orexin/hypocretin treatment restores hippocampal-dependent
memory in orexin-deficient mice. Neurobiol. Learn. Mem. 146, 21–30.
doi: 10.1016/j.nlm.2017.10.014
McGregor, R., Shan, L., Wu, M. F., and Siegel, J. M. (2017). Diurnal fluctuation
in the number of hypocretin/orexin and histamine producing: implication for
understanding and treating neuronal loss. PLoS One 12:e0178573. doi: 10.1371/
journal.pone.0178573
McGregor, R., Wu, M.-F., Barber, G., Ramanathan, L., and Siegel, J. M. (2011).
Highly specific role of hypocretin (orexin) neurons: differential activation as
a function of diurnal phase, operant reinforcement versus operant avoidance
and light level. J. Neurosci. 31, 15455–15467. doi: 10.1523/JNEUROSCI.4017-
11.2011
Megías, M., Emri, Z., Freund, T., and Gulyás, A. (2001). Total number and
distribution of inhibitory and excitatory synapses on hippocampal CA1
pyramidal cells. Neuroscience 102, 527–540. doi: 10.1016/S0306-4522(00)
00496-6
Mickelsen, L. E., Kolling, F. W., Chimileski, B. R., Fujita, A., Norris, C., Chen, K.,
et al. (2017). Neurochemical heterogeneity among lateral hypothalamic
hypocretin/orexin and melanin-concentrating hormone neurons identified
through single-cell gene expression analysis. eNeuro 4:ENEURO.0013-17.2017.
doi: 10.1523/ENEURO.0013-17.2017
Mileykovskiy, B. Y., Kiyashchenko, L. I., and Siegel, J. M. (2005). Behavioral
correlates of activity in identified hypocretin/orexin neurons. Neuron 46,
787–798. doi: 10.1016/j.neuron.2005.04.035
Miyamoto, A., Wake, H., Moorhouse, A. J., and Nabekura, J. (2013). Microglia and
synapse interactions: fine tuning neural circuits and candidate molecules. Front.
Cell. Neurosci. 7:70. doi: 10.3389/fncel.2013.00070
Modirrousta, M., Mainville, L., and Jones, B. E. (2005). Orexin and MCH neurons
express c-Fos differently after sleep deprivation vs. recovery and bear different
adrenergic receptors. Eur. J. Neurosci. 21, 2807–2816. doi: 10.1111/j.1460-9568.
2005.04104.x
Muraki, Y. (2004). Serotonergic regulation of the orexin/hypocretin neurons
through the 5-HT1A receptor. J. Neurosci. 24, 7159–7166. doi: 10.1523/
JNEUROSCI.1027-04.2004
Nixon, J. P., and Smale, L. (2007). A comparative analysis of the distribution of
immunoreactive orexin A and B in the brains of nocturnal and diurnal rodents.
Behav. Brain Funct. 3:28. doi: 10.1186/1744-9081-3-28
Ntamati, N. R., and Lüscher, C. (2016). VTA projection neurons releasing GABA
and glutamate in the dentate gyrus. eNeuro 3:ENEURO.0137-16.2016. doi: 10.
1523/ENEURO.0137-16.2016
Ottem, E. N. (2004). Dual-phenotype GABA/glutamate neurons in adult preoptic
area: sexual dimorphism and function. J. Neurosci. 24, 8097–8105. doi: 10.1523/
JNEUROSCI.2267-04.2004
Parsons, M. P., and Hirasawa, M. (2011). GIRK channel-mediated inhibition
of melanin-concentrating hormone neurons by nociceptin/orphanin FQ.
J. Neurophysiol. 105, 1179–1184. doi: 10.1152/jn.00791.2010
Perin, M., Longordo, F., Massonnet, C., Welker, E., and Lüthi, A. (2014). Diurnal
inhibition of NMDA-EPSCs at rat hippocampal mossy fibre synapses through
orexin-2 receptors. J. Physiol. 592, 4277–4295. doi: 10.1113/jphysiol.2014.
272757
Petsakou, A., Sapsis, T. P., and Blau, J. (2015). Circadian rhythms in Rho1
activity regulate neuronal plasticity and network hierarchy. Cell 162, 823–835.
doi: 10.1016/j.cell.2015.07.010
Peyron, C., and Kilduff, T. S. (2017). Mapping the hypocretin/orexin neuronal
system: an unexpectedly productive journey. J. Neurosci. 37, 2268–2272.
doi: 10.1523/JNEUROSCI.1708-16.2016
Peyron, C., Tighe, D. K., van den Pol, A. N., de Lecea, L., Heller, H. C., Sutcliffe,
J. G., et al. (1998). Neurons containing hypocretin (orexin) project to multiple
neuronal systems. J. Neurosci 18, 9996–10015. doi: 10.1523/JNEUROSCI.18-
23-09996.1998
Piper, D. C., Upton, N., Smith, M. I., and Hunter, A. J. (2000). The novel brain
neuropeptide, orexin-A, modulates the sleep-wake cycle of rats. Eur. J. Neurosci.
12, 726–730. doi: 10.1046/j.1460-9568.2000.00919.x
Rao, Y., Liu, Z. W., Borok, E., Rabenstein, R. L., Shanabrough, M., Lu, M.,
et al. (2007). Prolonged wakefulness induces experience-dependent synaptic
plasticity in mouse hypocretin/orexin neurons. J. Clin. Invest. 117, 4022–4033.
doi: 10.1172/JCI32829
Rao, Y., Lu, M., Ge, F., Marsh, D. J., Qian, S., Wang, A. H., et al. (2008).
Regulation of synaptic efficacy in hypocretin/orexin-containing neurons by
melanin concentrating hormone in the lateral hypothalamus. J. Neurosci. 28,
9101–9110. doi: 10.1523/JNEUROSCI.1766-08.2008
Razavi, B. M., and Hosseinzadeh, H. (2017). A review of the role of orexin system
in pain modulation. Biomed. Pharmacother. 90, 187–193. doi: 10.1016/j.biopha.
2017.03.053
Sakurai, T. (2007). The neural circuit of orexin (hypocretin): maintaining sleep and
wakefulness. Nat. Rev. Neurosci. 8, 171–181. doi: 10.1038/nrn2092
Sakurai, T. (2014). The role of orexin in motivated behaviours. Nat. Rev. Neurosci.
15, 719–731. doi: 10.1038/nrn3837
Sakurai, T., Amemiya, A., Ishii, M., Matsuzaki, I., Chemelli, R. M., Tanaka, H., et al.
(1998). Orexins and orexin receptors: a family of hypothalamic neuropeptides
and G protein-coupled receptors that regulate feeding behavior. Cell 92,
573–585. doi: 10.1016/S0092-8674(00)80949-6
Sakurai, T., and Mieda, M. (2011). Connectomics of orexin-producing
neurons: interface of systems of emotion, energy homeostasis and
arousal. Trends Pharmacol. Sci. 32, 451–462. doi: 10.1016/j.tips.2011.
03.007
Sakurai, T., Nagata, R., Yamanaka, A., Kawamura, H., Tsujino, N., Muraki, Y., et al.
(2005). Input of orexin/hypocretin neurons revealed by a genetically encoded
tracer in mice. Neuron 46, 297–308. doi: 10.1016/j.neuron.2005.03.010
Salomon, R. M., Ripley, B., Kennedy, J. S., Johnson, B., Schmidt, D., Zeitzer,
J. M., et al. (2003). Diurnal variation of cerebrospinal fluid hypocretin-1
(Orexin-A) levels in control and depressed subjects. Biol. Psychiatry 54, 96–104.
doi: 10.1016/S0006-3223(03)01740-7
Saper, C. B., Lu, J., Chou, T. C., and Gooley, J. (2005). The hypothalamic integrator
for circadian rhythms. Trends Neurosci. 28, 152–157. doi: 10.1016/j.tins.2004.
12.009
Scammell, T. E. (2015). Narcolepsy. N. Engl. J. Med. 373, 2654–2662. doi: 10.1056/
NEJMra1500587
Scammell, T. E., Arrigoni, E., and Lipton, J. O. (2017). Neural circuitry of
wakefulness and sleep. Neuron 93, 747–765. doi: 10.1016/j.neuron.2017.
01.014
Schöne, C., Apergis-Schoute, J., Sakurai, T., Adamantidis, A., and Burdakov, D.
(2014). Coreleased orexin and glutamate evoke nonredundant spike outputs
and computations in histamine neurons. Cell Rep. 7, 697–704. doi: 10.1016/j.
celrep.2014.03.055
Schöne, C., Cao, Z. F. H., Apergis-Schoute, J., Adamantidis, A., Sakurai, T., and
Burdakov, D. (2012). Optogenetic probing of fast glutamatergic transmission
from hypocretin/orexin to histamine neurons in situ. J. Neurosci. 32,
12437–12443. doi: 10.1523/JNEUROSCI.0706-12.2012
Sears, R. M., Fink, A. E., Wigestrand, M. B., Farb, C. R., de Lecea, L., and LeDoux,
J. E. (2013). Orexin/hypocretin system modulates amygdala-dependent threat
learning through the locus coeruleus. Proc. Natl. Acad. Sci. U.S.A. 110,
20260–20265. doi: 10.1073/pnas.1320325110
Shabel, S. J., Proulx, C. D., Piriz, J., and Malinow, R. (2014). GABA/glutamate co-
release controls habenula output and is modified by antidepressant treatment.
Science 345, 1494–1498. doi: 10.1126/science.1250469
Sharma, S., Fernandes, M. F., and Fulton, S. (2013). Adaptations in brain
reward circuitry underlie palatable food cravings and anxiety induced by
high-fat diet withdrawal. Int. J. Obes. 37, 1183–1191. doi: 10.1038/ijo.
2012.197
Song, I., and Dityatev, A. (2017). Crosstalk between glia, extracellular matrix and
neurons. Brain Res. Bull. 136, 101–108. doi: 10.1016/j.brainresbull.2017.03.003
Spruston, N. (2008). Pyramidal neurons: dendritic structure and
synaptic integration. Nat. Rev. Neurosci. 9, 206–221. doi: 10.1038/
nrn2286
Stanley, E. M., and Fadel, J. (2012). Aging-related deficits in orexin/hypocretin
modulation of the septohippocampal cholinergic system. Synapse 66, 445–452.
doi: 10.1002/syn.21533
Steininger, T. L., and Kilduff, T. S. (2005). “Anatomy of the Hypocretin System,” in
Hypocretins, eds L. de Lecea and J. G. Sutcliffe (Boston, MA: Springer), 61–75.
doi: 10.1007/0-387-25446-3_5
Taheri, S., Sunter, D., Dakin, C., Moyes, S., Seal, L., Gardiner, J., et al. (2000).
Diurnal variation in orexin A immunoreactivity and prepro-orexin mRNA
in the rat central nervous system. Neurosci. Lett. 279, 109–112. doi: 10.1016/
S0304-3940(99)00955-6
Frontiers in Pharmacology | www.frontiersin.org 15 September 2018 | Volume 9 | Article 1061
fphar-09-01061 September 22, 2018 Time: 15:4 # 16
Azeez et al. Daily Fluctuation of Orexin Neuron Wiring
Takahashi, K., Lin, J. S., and Sakai, K. (2008). Neuronal activity of orexin
and non-orexin waking-active neurons during wake-sleep states in the
mouse. Neuroscience 153, 860–870. doi: 10.1016/j.neuroscience.2008.
02.058
Thannickal, T. C., Moore, R. Y., Nienhuis, R., Ramanathan, L., Gulyani, S.,
Aldrich, M., et al. (2000). Reduced number of hypocretin neurons in human
narcolepsy. Neuron 27, 469–474. doi: 10.1016/S0896-6273(00)00058-1
Thannickal, T. C., Nienhuis, R., and Siegel, J. M. (2009). Localized loss of
hypocretin (orexin) cells in narcolepsy without cataplexy. Sleep 32, 993–998.
doi: 10.1093/sleep/32.8.993
Tononi, G., and Cirelli, C. (2003). Sleep and synaptic homeostasis: a hypothesis.
Brain Res. Bull. 62, 143–150. doi: 10.1016/j.brainresbull.2003.09.004
Tononi, G., and Cirelli, C. (2014). Sleep and the price of plasticity: from synaptic
and cellular homeostasis to memory consolidation and integration. Neuron 81,
12–34. doi: 10.1016/j.neuron.2013.12.025
Toossi, H., del Cid-Pellitero, E., and Jones, B. E. (2016). GABA receptors on orexin
and MCH neurons are differentially homeostatically regulated following sleep
deprivation. eNeuro 3:ENEURO.0077-16.2016. doi: 10.1523/ENEURO.0077-
16.2016
Toossi, H., Del Cid-Pellitero, E., Stroh, T., and Jones, B. E. (2012). Somatostatin
varicosities contain the vesicular GABA transporter and contact orexin neurons
in the hypothalamus. Eur. J. Neurosci. 36, 3388–3395. doi: 10.1111/j.1460-9568.
2012.08253.x
Torrealba, F., Yanagisawa, M., and Saper, C. B. (2003). Colocalization of orexin A
and glutamate immunoreactivity in axon terminals in the tuberomammillary
nucleus in rats. Neuroscience 119, 1033–1044. doi: 10.1016/S0306-4522(03)
00238-0
Turrigiano, G. G. (1999). Homeostatic plasticity in neuronal networks: the more
things change, the more they stay the same. Trends Neurosci. 22, 221–227.
doi: 10.1016/S0166-2236(98)01341-1
Tyree, S. M., Borniger, J. C., and de Lecea, L. (2018). Hypocretin as a hub for arousal
and motivation. Front. Neurol. 9:413. doi: 10.3389/fneur.2018.00413
Tyree, S. M., and de Lecea, L. (2017). Lateral hypothalamic control of the ventral
tegmental area: reward evaluation and the driving of motivated behavior. Front.
Syst. Neurosci. 11:50. doi: 10.3389/fnsys.2017.00050
van den Pol, A. N. (1999). Hypothalamic hypocretin (orexin): robust innervation
of the spinal cord. J. Neurosci. 19, 3171–3182. doi: 10.1523/JNEUROSCI.19-08-
03171.1999
Verret, L., Goutagny, R., Fort, P., Cagnon, L., Salvert, D., Léger, L., et al. (2003).
A role of melanin-concentrating hormone producing neurons in the central
regulation of paradoxical sleep. BMC Neurosci. 4:19. doi: 10.1186/1471-2202-
4-19
Winsky-Sommerer, R. (2004). Interaction between the corticotropin-releasing
factor system and hypocretins (orexins): a novel circuit mediating stress
response. J. Neurosci. 24, 11439–11448. doi: 10.1523/JNEUROSCI.3459-04.
2004
Wojcik, S. M., Katsurabayashi, S., Guillemin, I., Friauf, E., Rosenmund, C.,
Brose, N., et al. (2006). A shared vesicular carrier allows synaptic corelease of
GABA and glycine. Neuron 50, 575–587. doi: 10.1016/j.neuron.2006.04.016
Wouterlood, F. G., Böckers, T., and Witter, M. P. (2003). Synaptic contacts between
identified neurons visualized in the confocal laser scanning microscope.
Neuroanatomical tracing combined with immunofluorescence detection of
post-synaptic density proteins and target neuron-markers. J. Neurosci. Methods.
128, 129–142. doi: 10.1016/S0165-0270(03)00171-7
Wouterlood, F. G., Boekel, A. J., Meijer, G. A., and Beliën, J. A. M. (2007).
Computer-assisted estimation in the CNS of 3D multimarker “overlap” or
“touch” at the level of individual nerve endings: a confocal laser scanning
microscope application. J. Neurosci. Res. 85, 1215–1228. doi: 10.1002/jnr.21244
Wu, M.-F., John, J., Maidment, N., Lam, H. A., and Siegel, J. M. (2002). Hypocretin
release in normal and narcoleptic dogs after food and sleep deprivation, eating,
and movement. Am. J. Physiol. Integr. Comp. Physiol. 283, R1079–R1086.
doi: 10.1152/ajpregu.00207.2002
Yamanaka, A., Beuckmann, C. T., Willie, J. T., Hara, J., Tsujino, N., Mieda, M., et al.
(2003a). Hypothalamic orexin neurons regulate arousal according to energy
balance in mice. Neuron 38, 701–713. doi: 10.1016/S0896-6273(03)00331-3
Yamanaka, A., Muraki, Y., Tsujino, N., Goto, K., and Sakurai, T. (2003b).
Regulation of orexin neurons by the monoaminergic and cholinergic systems.
Biochem. Biophys. Res. Commun. 303, 120–129. doi: 10.1016/S0006-291X(03)
00299-7
Yamanaka, A., Tabuchi, S., Tsunematsu, T., Fukazawa, Y., and Tominaga, M.
(2010). Orexin directly excites orexin neurons through orexin 2
receptor. J. Neurosci. 30, 12642–12652. doi: 10.1523/JNEUROSCI.2120-
10.2010
Yamanaka, A., Tsujino, N., Goto, K., Sakurai, T., Funahashi, H., Guan, J. L.,
et al. (2002). Orexins activate histaminergic neurons via the orexin 2 receptor.
Biochem. Biophys. Res. Commun. 290, 1237–1245. doi: 10.1006/bbrc.2001.
6318
Yamuy, J., Fung, S. J., Xi, M., and Chase, M. H. (2004). Hypocretinergic
control of spinal cord motoneurons. J. Neurosci. 24, 5336–5345. doi: 10.1523/
JNEUROSCI.4812-03.2004
Yoshida, K., McCormack, S., España, R. A., Crocker, A., and Scammell, T. E. (2006).
Afferents to the orexin neurons of the rat brain. J. Comp. Neurol. 494, 845–861.
doi: 10.1002/cne.20859
Yoshida, Y., Fujiki, N., Nakajima, T., Ripley, B., Matsumura, H., Yoneda, H., et al.
(2001). Fluctuation of extracellular hypocretin-1 (orexin A) levels in the rat in
relation to the light-dark cycle and sleep-wake activities. Eur. J. Neurosci. 14,
1075–1081. doi: 10.1046/j.0953-816X.2001.01725.x
Zander, J.-F., Munster-Wandowski, A., Brunk, I., Pahner, I., Gomez-Lira, G.,
Heinemann, U., et al. (2010). Synaptic and vesicular coexistence of VGLUT
and VGAT in selected excitatory and inhibitory synapses. J. Neurosci. 30,
7634–7645. doi: 10.1523/JNEUROSCI.0141-10.2010
Zeitzer, J. M., Buckmaster, C. L., Lyons, D. M., and Mignot, E. (2004).
Locomotor-dependent and -independent components to hypocretin-1 (orexin
A) regulation in sleep-wake consolidating monkeys. J. Physiol. 557, 1045–1053.
doi: 10.1113/jphysiol.2004.061606
Zeitzer, J. M., Buckmaster, C. L., Parker, K. J., Hauck, C. M., Lyons,
D. M., and Mignot, E. (2003). Circadian and homeostatic regulation of
hypocretin in a primate model: implications for the consolidation of
wakefulness. J. Neurosci. 23, 3555–3560. doi: 10.1523/JNEUROSCI.23-08-035
55.2003
Zhang, S., Zeitzer, J. M., Yoshida, Y., Wisor, J. P., Nishino, S., Edgar, D. M.,
et al. (2004). Lesions of the suprachiasmatic nucleus eliminate the daily
rhythm of hypocretin-1 release. Sleep 27, 619–627. doi: 10.1093/sleep/
27.4.619
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2018 Azeez, Del Gallo, Cristino and Bentivoglio. This is an open-access
article distributed under the terms of the Creative Commons Attribution License
(CC BY). The use, distribution or reproduction in other forums is permitted, provided
the original author(s) and the copyright owner(s) are credited and that the original
publication in this journal is cited, in accordance with accepted academic practice.
No use, distribution or reproduction is permitted which does not comply with these
terms.
Frontiers in Pharmacology | www.frontiersin.org 16 September 2018 | Volume 9 | Article 1061
